https://trial.medpath.com/news/diamyd-medical-receives-u-s-fda-fast-track-designation-for-diamyd-r 2010-01-01T00:00:00+00:00 weekly 0.7 https://trial.medpath.com/news/new-publication-highlights-safety-and-potential-benefits-of-redosing 2010-01-01T00:00:00+00:00 weekly 0.7 https://trial.medpath.com/news/results-from-diamyd-r-antigen-specific-immunotherapy-trial-in-lada 2010-01-01T00:00:00+00:00 weekly 0.7 https://trial.medpath.com/news/diamyd-medical-new-publication-highlights-safety-and 2010-01-01T00:00:00+00:00 weekly 0.7 https://trial.medpath.com/news/diamyd-medical-receives-positive-feedback-from-fda-on-potential 2010-01-01T00:00:00+00:00 weekly 0.7 https://trial.medpath.com/news/fda-approves-bexlutry-first-generic-radioligand-therapy-after-curium-wins-novartis-patent-dispute 2026-09-15T21:53:37+00:00 hourly 0.9 https://trial.medpath.com/news/royalty-pharma-gives-7-5m-to-blood-cancer-united-s-therapy-acceleration-program-marking-new-venture-philanthropy-phase 2026-09-15T21:53:06+00:00 hourly 0.9 https://trial.medpath.com/news/uc-davis-launches-14-05m-we-cair-program-to-decode-wildfire-smoke-s-cardiovascular-and-airway-damage 2026-09-15T17:50:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-and-hsa-flag-vitamin-b6-deficiency-and-seizure-risk-with-carbidopa-levodopa-and-benserazide-levodopa 2026-09-15T16:51:38+00:00 hourly 0.9 https://trial.medpath.com/news/openai-foundation-grants-unc-lineberger-40m-to-sharpen-personalized-cancer-vaccine-design 2026-09-15T16:50:20+00:00 hourly 0.9 https://trial.medpath.com/news/dr-reddy-s-launches-nivorz-india-s-in-house-nivolumab-biosimilar-across-12-oncology-indications 2026-09-15T16:50:19+00:00 hourly 0.9 https://trial.medpath.com/news/evvy-raises-40m-series-b-to-scale-ai-driven-vaginal-microbiome-diagnostics-and-enter-fertility 2026-09-15T16:50:01+00:00 hourly 0.9 https://trial.medpath.com/news/hexembio-raises-15-5m-to-advance-stem-cell-rejuvenation-platform-into-three-product-generations 2026-09-15T14:50:14+00:00 hourly 0.9 https://trial.medpath.com/news/revive-therapeutics-to-expand-bucillamine-ip-and-orphan-drug-portfolio-across-medical-countermeasures-and-rare-diseases 2026-09-15T14:49:30+00:00 hourly 0.9 https://trial.medpath.com/news/elvinix-licenses-zealand-pharma-s-glp-1-gastrin-dual-agonist-peptides-for-beta-cell-regeneration-in-type-1-diabetes 2026-09-15T14:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/asahi-kasei-bioprocess-debuts-vantij-su-vfc-benchtop-for-automated-single-use-virus-filtration-in-gene-therapy-manufacturing 2026-09-15T12:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/japan-approves-buphenyl-sodium-phenylbutyrate-for-pfic-types-1-and-2-after-20-year-research-effort 2026-09-15T12:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/immupharma-s-p140-cuts-inflammation-and-fibrosis-in-mash-model-as-company-files-international-patent-for-type-m-precision-medicine 2026-09-15T11:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/compounded-glp-1-telehealth-comparison-highlights-pricing-clinician-review-and-fda-approval-gaps 2026-09-15T10:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/lobe-sciences-to-present-phase-1a-low-dose-psilocin-data-for-l-130-at-neuropsychiatric-drug-development-summit 2026-09-15T10:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/scaffold-free-3d-cell-culture-market-poised-for-growth-through-2033-as-labs-seek-physiologically-relevant-in-vitro-models 2026-09-15T10:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/nih-backs-12-8m-multi-university-project-to-model-how-female-hormones-alter-drug-processing 2026-09-15T04:48:40+00:00 hourly 0.9 https://trial.medpath.com/news/aptar-and-massachusetts-general-hospital-partner-to-build-predictive-nose-to-brain-screening-platform-for-cns-drugs 2026-09-15T01:48:56+00:00 hourly 0.9 https://trial.medpath.com/news/bipartisan-bill-would-make-rare-pediatric-disease-drug-incentive-program-permanent 2026-09-15T00:56:02+00:00 hourly 0.9 https://trial.medpath.com/news/beta-bionics-wins-fda-clearance-for-mint-patch-pump-submits-3d-intelligence-insulin-dosing-algorithm 2026-09-15T00:55:42+00:00 hourly 0.9 https://trial.medpath.com/news/ou-health-campus-launches-ai-push-to-tackle-oklahoma-s-bottom-tier-health-outcomes 2026-09-14T22:54:35+00:00 hourly 0.9 https://trial.medpath.com/news/updated-mrna-covid-19-vaccines-roll-out-at-united-family-pharmacies-ahead-of-respiratory-virus-season 2026-09-14T21:50:05+00:00 hourly 0.9 https://trial.medpath.com/news/adme-toxicology-testing-market-outlook-2026-2030-north-america-leads-as-asia-pacific-emerges-as-fastest-growing-region 2026-09-14T17:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/santa-ana-bio-doses-first-cohort-in-phase-1-trial-of-kit-siglec-6-bispecific-antibody-sab01-for-mast-cell-depletion 2026-09-14T16:49:52+00:00 hourly 0.9 https://trial.medpath.com/news/sanofi-to-divest-20-mature-medicines-and-three-manufacturing-sites-to-cheplapharm-in-equity-linked-partnership 2026-09-14T16:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/penn-state-health-s-food-as-medicine-initiative-links-24-gardens-six-community-fridges-to-diet-related-disease-research 2026-09-14T15:49:29+00:00 hourly 0.9 https://trial.medpath.com/news/alveus-doses-first-patient-in-phase-2-preserve-trial-of-alv-100-for-weight-maintenance-after-semaglutide 2026-09-14T14:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-biofrontera-s-ameluz-red-light-pdt-for-superficial-basal-cell-carcinoma 2026-09-14T14:49:40+00:00 hourly 0.9 https://trial.medpath.com/news/us-weight-loss-drug-trial-reports-breakthrough-with-fewer-side-effects 2026-09-14T14:49:30+00:00 hourly 0.9 https://trial.medpath.com/news/fda-accepts-organon-s-snda-to-extend-hormone-free-iud-miudella-to-six-years-of-use 2026-09-14T13:51:21+00:00 hourly 0.9 https://trial.medpath.com/news/china-nmpa-accepts-bla-for-longbio-s-anti-ige-antibody-lp-003-in-seasonal-allergic-rhinitis 2026-09-14T13:51:05+00:00 hourly 0.9 https://trial.medpath.com/news/shennon-biotechnologies-raises-12m-names-cyril-konto-ceo-and-unveils-three-t-cell-engager-programs 2026-09-14T13:51:04+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-ind-for-ipn60330-first-mait-cell-engager-paving-way-for-phase-1-in-solid-tumors 2026-09-14T13:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/evaxion-expands-ai-immunology-platform-into-autoimmune-diseases-with-two-novel-treatment-concepts 2026-09-14T13:51:02+00:00 hourly 0.9 https://trial.medpath.com/news/geneuro-wins-european-patent-for-gnk-301-an-anti-herv-k-antibody-targeting-als 2026-09-14T13:50:25+00:00 hourly 0.9 https://trial.medpath.com/news/love-serving-autism-brings-young-athletes-with-autism-to-center-court-at-the-us-open 2026-09-14T13:50:22+00:00 hourly 0.9 https://trial.medpath.com/news/fda-accepts-orexo-s-ind-for-needle-free-intranasal-epinephrine-powder-ox640-in-anaphylaxis 2026-09-14T10:42:04+00:00 hourly 0.9 https://trial.medpath.com/news/whitehawk-data-at-wclc-2026-position-ptk7-as-durable-treatment-agnostic-adc-target-in-egfr-wild-type-nsclc 2026-09-14T02:48:48+00:00 hourly 0.9 https://trial.medpath.com/news/huons-wins-three-state-drug-development-grants-to-advance-mrna-eye-drop-adc-and-peptide-cancer-drug 2026-09-14T02:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/falls-in-older-adults-14-million-report-falling-annually-as-clinicians-push-prevention-over-inevitability 2026-09-14T00:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/bausch-lomb-s-seelyra-femtosecond-laser-wins-european-ce-mark 2026-09-13T20:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/medipal-and-jcr-dose-first-patient-in-global-phase-i-ii-trial-of-jr-446-for-sanfilippo-syndrome-type-b 2026-09-13T19:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/tatyana-ali-turns-traumatic-birth-into-advocacy-for-black-and-indigenous-maternal-health 2026-09-13T16:48:48+00:00 hourly 0.9 https://trial.medpath.com/news/phase-iii-maverick-trial-backs-brain-mri-surveillance-alone-dropping-prophylactic-cranial-irradiation-in-sclc 2026-09-13T13:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/jaguar-laa-acquires-j-j-s-laminar-program-marking-j-j-s-exit-from-laa-closure-market 2026-09-13T09:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/apr-s-rf-microporation-boosts-minoxidil-skin-deposition-2-4x-in-preclinical-hair-loss-study 2026-09-13T06:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/roche-partner-medilink-s-b7-h3-adc-tam-peli-cuts-death-risk-54-in-relapsed-sclc-phase-iii 2026-09-13T01:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/chek2-mutation-drives-third-cancer-in-15-years-as-patient-begins-lifelong-herceptin-for-stage-four-disease 2026-09-12T23:48:32+00:00 hourly 0.9 https://trial.medpath.com/news/perzeption-wins-nei-phase-i-sbir-grant-to-develop-tablet-based-photostress-recovery-test-for-amd 2026-09-12T22:53:57+00:00 hourly 0.9 https://trial.medpath.com/news/mebendazole-cancer-claims-outrun-the-evidence-experts-warn-as-johns-hopkins-patent-fuels-viral-posts 2026-09-12T20:49:08+00:00 hourly 0.9 https://trial.medpath.com/news/cdph-warns-against-happy-hens-organic-shell-eggs-as-salmonella-enteritidis-outbreak-sickens-23-in-california 2026-09-12T20:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/opus-genetics-phentolamine-eye-drops-improve-dim-light-vision-in-phase-iii-lynx-1-trial 2026-09-12T18:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/bloating-led-to-stage-4-ovarian-cancer-diagnosis-oncologist-highlights-very-insidious-disease-with-no-screening-test 2026-09-12T18:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/sskm-hospital-administers-first-us-approved-alzheimer-s-drug-in-eastern-india 2026-09-12T16:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/rare-sst-chodl-cortical-neurons-actively-drive-the-transition-into-sleep-nature-study-finds 2026-09-12T12:56:02+00:00 hourly 0.9 https://trial.medpath.com/news/first-analysis-of-eight-myotis-bat-genomes-links-longevity-to-antiviral-and-cancer-suppressing-immunity 2026-09-12T01:48:31+00:00 hourly 0.9 https://trial.medpath.com/news/radiotherapy-plus-immunotherapy-in-oligometastatic-nsclc-review-maps-path-to-individualized-multimodal-care 2026-09-12T00:52:24+00:00 hourly 0.9 https://trial.medpath.com/news/hormone-therapy-in-breast-and-prostate-cancer-receptor-degraders-target-treatment-resistance 2026-09-12T00:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/ub-awarded-5-million-to-lead-suny-brain-institute-hub-for-age-related-brain-disorders 2026-09-12T00:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/dietary-supplement-innovation-act-targets-fda-s-drug-preclusion-clause 2026-09-11T21:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/pennsylvania-reports-four-measles-breakthrough-cases-in-fully-vaccinated-residents-amid-largest-outbreak-in-30-years 2026-09-11T20:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/sanofi-and-usa-pickleball-launch-serve-up-protection-campaign-to-boost-awareness-of-protein-based-nuvaxovid-covid-19-vaccine 2026-09-11T20:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/entrectinib-safety-signals-in-nsclc-replicated-across-faers-and-jader-with-early-neurologic-cardiac-and-renal-events 2026-09-11T19:48:45+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-breakthrough-device-designation-to-nutromics-wearable-vancomycin-monitoring-patch 2026-09-11T17:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/allogenetics-raises-eur3-8m-pre-series-a-to-advance-ex-vivo-gene-therapy-for-rejection-resistant-donor-lungs 2026-09-11T16:50:24+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-holds-pharma-r-d-lead-as-obesity-pipeline-swells-30-7-and-rare-disease-share-rises 2026-09-11T15:55:53+00:00 hourly 0.9 https://trial.medpath.com/news/efemp1-p-arg140trp-variant-identified-as-cause-of-newly-recognized-late-onset-retinal-degeneration 2026-09-11T15:55:16+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-capture-dna-strands-zipping-together-offering-new-clues-to-cancer-and-genome-organization 2026-09-11T15:55:12+00:00 hourly 0.9 https://trial.medpath.com/news/adhd-linked-to-nearly-50-higher-odds-of-gastrointestinal-symptoms-in-1-9-million-person-review 2026-09-11T15:55:03+00:00 hourly 0.9 https://trial.medpath.com/news/alltrna-doses-first-trna-therapy-in-humans-as-ap003-phase-1-begins-in-australia 2026-09-11T13:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/hiti-genome-editing-repairs-native-otc-gene-in-liver-cells-offering-mutation-agnostic-strategy-for-pediatric-gene-therapy 2026-09-11T13:49:08+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-therapy-reshapes-mutant-cell-selection-in-normal-esophagus-sanger-led-study-finds 2026-09-11T12:49:28+00:00 hourly 0.9 https://trial.medpath.com/news/ontario-wide-study-identifies-24-common-prescribing-cascades-driving-drug-harm-in-older-adults 2026-09-11T12:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/dupilumab-linked-ocular-surface-disease-affects-nearly-one-third-of-atopic-dermatitis-patients-but-rarely-forces-discontinuation 2026-09-11T12:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/step-volume-or-step-pace-large-cohort-study-finds-both-walking-strategies-lower-mortality-risk 2026-09-11T12:48:56+00:00 hourly 0.9 https://trial.medpath.com/news/korea-issues-early-influenza-advisory-as-cases-hit-twice-the-epidemic-threshold 2026-09-11T10:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/padeliporfin-vtp-converts-inoperable-pancreatic-tumors-to-resectable-in-early-phase-1-data 2026-09-11T10:48:33+00:00 hourly 0.9 https://trial.medpath.com/news/esmo-commits-eur1-million-to-fund-academic-cancer-trials-targeting-treatment-de-escalation-and-care-optimization 2026-09-11T08:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/pelacarsen-and-ziltivekimab-fail-late-stage-trials-ending-the-genetics-is-undefeated-era-in-cardiovascular-drug-development 2026-09-11T06:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/time100-health-forum-experts-point-to-vaccines-immunotherapy-and-early-detection-as-path-to-curing-cancer 2026-09-11T03:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/uab-chemists-advance-targeted-alpha-therapy-with-astatine-211-and-theragnostic-nanomaterials 2026-09-11T02:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/mitsui-signs-service-agreement-with-oncoshot-to-build-asia-us-oncology-real-world-data-network 2026-09-11T02:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/lancet-publication-details-phase-3-win-for-csl-seqirus-s-triple-enhanced-aqivc-influenza-vaccine-in-older-adults 2026-09-11T01:48:37+00:00 hourly 0.9 https://trial.medpath.com/news/landmark-il-2-discovery-50-years-on-recognized-as-foundation-of-modern-cancer-immunotherapy 2026-09-10T22:54:37+00:00 hourly 0.9 https://trial.medpath.com/news/shoulder-innovations-wins-fda-510-k-clearance-for-n-22-humeral-head-launches-titanium-implant-for-metal-sensitive-patients 2026-09-10T21:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/immunotherapy-not-chemotherapy-drives-hair-repigmentation-in-thoracic-cancer-patients 2026-09-10T19:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-ide-approval-to-ciliatech-for-intercil-uveal-spacer-glaucoma-feasibility-study 2026-09-10T19:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/salk-team-maps-how-chronic-interferon-ii-drives-immunosuppression-and-anti-pd1-resistance-in-melanoma 2026-09-10T19:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/tennor-s-rifaquizinone-achieves-100-success-in-early-periprosthetic-joint-infection-phase-iib-trial-underway 2026-09-10T18:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/bgi-group-unveils-digital-life-twin-framework-and-multimodal-brain-on-chip-at-2026-global-launch 2026-09-10T17:49:24+00:00 hourly 0.9 https://trial.medpath.com/news/graph-ai-raises-13-3m-series-a-to-scale-ai-native-pharmacovigilance-platform 2026-09-10T17:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/penn-medicine-receives-50-million-gift-to-fund-early-stage-cancer-autoimmune-and-infectious-disease-research 2026-09-10T17:48:45+00:00 hourly 0.9 https://trial.medpath.com/news/maia-biotechnology-unveils-next-generation-telomere-targeting-prodrugs-at-irt-2026 2026-09-10T17:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/columbia-university-irving-medical-center-and-aws-partner-to-accelerate-ai-driven-biomarker-and-diagnostic-discovery 2026-09-10T16:49:50+00:00 hourly 0.9 https://trial.medpath.com/news/biolife-secures-u-s-patent-for-effervescent-oral-peptide-delivery-technology-covering-glp-1-receptor-agonists 2026-09-10T16:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/bmj-investigation-half-of-england-s-icbs-impose-minimum-waits-of-up-to-16-weeks-for-elective-surgery 2026-09-10T16:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/nighttime-light-exposure-linked-to-cardiac-remodelling-in-11000-person-uk-biobank-study 2026-09-10T16:48:59+00:00 hourly 0.9 https://trial.medpath.com/news/obviohealth-and-sprim-pro-launch-integrated-digital-patient-monitoring-solution-for-high-risk-therapies 2026-09-10T16:48:33+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-ind-for-prelude-therapeutics-first-in-class-oral-kat6a-degrader-prt13722-in-hr-her2-breast-cancer 2026-09-10T14:50:38+00:00 hourly 0.9 https://trial.medpath.com/news/nccn-survey-all-responding-cancer-centers-report-at-least-one-anticancer-drug-shortage-as-ifosfamide-gaps-hit-94 2026-09-10T14:50:35+00:00 hourly 0.9 https://trial.medpath.com/news/eib-and-hera-commit-eur30m-to-ethris-for-broad-spectrum-nasal-antiviral-mrna 2026-09-10T14:49:49+00:00 hourly 0.9 https://trial.medpath.com/news/headlands-research-opens-de-novo-grand-rapids-site-to-meet-rising-rheumatology-trial-demand 2026-09-10T14:49:38+00:00 hourly 0.9 https://trial.medpath.com/news/our-future-health-cohort-tops-1-9-million-participants-mapping-disease-patterns-across-the-uk 2026-09-10T14:49:33+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-26m-to-advance-ri-ctr-for-third-five-year-phase-of-clinical-and-translational-research 2026-09-10T14:49:32+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-launches-early-life-exposure-research-center-to-track-9-11-health-effects-in-youngest-survivors 2026-09-10T14:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/teitur-trophics-first-in-class-peptide-tt-p34-clears-phase-i-in-parkinson-s-confirming-brain-exposure 2026-09-10T12:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/matterhorn-final-os-perioperative-durvalumab-plus-flot-cuts-death-risk-22-in-resectable-gastric-gej-cancer 2026-09-10T11:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/tevard-biosciences-publishes-preclinical-data-on-engineered-suppressor-trna-gene-therapy-for-duchenne-muscular-dystrophy 2026-09-10T10:48:44+00:00 hourly 0.9 https://trial.medpath.com/news/four-japanese-researchers-win-lasker-awards-for-sleep-science-and-hemophilia-drug-hemlibra 2026-09-10T08:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/methylglyoxal-stress-drives-immune-suppression-and-immunotherapy-resistance-in-triple-negative-breast-cancer 2026-09-10T03:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/beeline-medicines-afimetoran-hits-primary-endpoint-in-global-phase-2-sle-trial-advancing-to-pivotal-development 2026-09-10T00:50:22+00:00 hourly 0.9 https://trial.medpath.com/news/25000-year-old-teeth-reveal-earliest-known-evidence-of-human-drug-use 2026-09-10T00:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/stamina-trial-supervised-exercise-and-diet-program-cuts-quality-of-life-decline-by-a-third-in-men-on-androgen-deprivation-therapy 2026-09-09T23:48:48+00:00 hourly 0.9 https://trial.medpath.com/news/seismic-pharmaceuticals-commences-global-phase-3-trial-of-istaroxime-for-cardiogenic-shock 2026-09-09T22:59:02+00:00 hourly 0.9 https://trial.medpath.com/news/beren-therapeutics-and-genedx-launch-test-for-npc-to-accelerate-diagnosis-of-niemann-pick-disease-type-c 2026-09-09T22:58:36+00:00 hourly 0.9 https://trial.medpath.com/news/cellipont-and-xiogenix-white-paper-shows-automated-fill-finish-maintains-cell-viability-across-17-fold-scale-up 2026-09-09T22:55:25+00:00 hourly 0.9 https://trial.medpath.com/news/apple-health-app-users-to-order-quest-diagnostics-biomarker-lab-panels-directly-in-app 2026-09-09T22:55:12+00:00 hourly 0.9 https://trial.medpath.com/news/navion-neurosciences-closes-10-8m-seed-financing-to-advance-precision-sodium-channel-medicines-for-epilepsy-and-neuropathic-pain 2026-09-09T22:54:47+00:00 hourly 0.9 https://trial.medpath.com/news/crossbow-therapeutics-doses-first-patient-in-phase-1-trial-of-first-in-class-t-cell-engager-cbx-663 2026-09-09T20:51:05+00:00 hourly 0.9 https://trial.medpath.com/news/1cbio-licenses-preclinical-parp1-inhibitor-oc-3-to-lee-s-pharm-for-greater-china-and-southeast-asia-in-deal-worth-up-to-27-million 2026-09-09T20:50:21+00:00 hourly 0.9 https://trial.medpath.com/news/twostep-therapeutics-raises-62-5m-series-a-and-wins-fda-ind-clearance-for-first-in-class-multi-specific-peptide-drug-conjugate-ts-104 2026-09-09T20:50:09+00:00 hourly 0.9 https://trial.medpath.com/news/bangladesh-measles-deaths-surpass-1000-as-vaccination-drive-falls-short-of-herd-immunity 2026-09-09T20:50:07+00:00 hourly 0.9 https://trial.medpath.com/news/fi-recalls-two-dog-supplement-lots-over-salmonella-contamination-risk 2026-09-09T20:50:02+00:00 hourly 0.9 https://trial.medpath.com/news/parabolus-medicines-zolocatetide-posts-74-response-rate-in-desmoid-tumors-targeting-the-undruggable-beta-catenin-tcf-complex 2026-09-09T20:50:00+00:00 hourly 0.9 https://trial.medpath.com/news/apple-s-revamped-health-app-adds-readiness-score-health-age-and-longevity-tracking 2026-09-09T20:49:59+00:00 hourly 0.9 https://trial.medpath.com/news/sars-cov-2-infection-linked-to-16-lower-risk-of-type-1-diabetes-in-under-30s-danish-registry-study-finds 2026-09-09T19:51:27+00:00 hourly 0.9 https://trial.medpath.com/news/two-independent-teams-converge-on-pla2g2d-as-a-novel-immune-checkpoint-to-overcome-anti-pd-1-resistance 2026-09-09T19:51:22+00:00 hourly 0.9 https://trial.medpath.com/news/large-echo-cohort-finds-no-link-between-prenatal-organophosphate-exposure-and-autism-related-traits 2026-09-09T19:50:55+00:00 hourly 0.9 https://trial.medpath.com/news/trialbee-launches-ai-pre-screening-agent-in-honey-platform-to-speed-trial-enrollment 2026-09-09T17:50:47+00:00 hourly 0.9 https://trial.medpath.com/news/rezera-s-oral-nlrp3-inhibitor-ruvonoflast-hits-primary-inflammation-endpoint-in-phase-2-resolve-1-phase-3-pad-trial-planned-for-2027 2026-09-09T17:50:46+00:00 hourly 0.9 https://trial.medpath.com/news/kazia-therapeutics-doses-first-patient-in-pnoc035-phase-2-trial-of-paxalisib-plus-gemcitabine-for-recurrent-pediatric-at-rt 2026-09-09T17:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/three-chugai-researchers-behind-hemlibra-discovery-receive-lasker-debakey-clinical-medical-research-award 2026-09-09T17:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-ind-for-full-life-s-actinium-225-c-met-radioconjugate-225ac-ac-fl-261-in-non-squamous-nsclc 2026-09-09T16:50:07+00:00 hourly 0.9 https://trial.medpath.com/news/cepi-awards-up-to-8-9m-to-pune-s-immunoscript-for-thermostable-sarna-vaccine-platform 2026-09-09T16:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/waldenstrom-macroglobulinemia-market-poised-for-steady-growth-through-2036-on-novel-btk-degraders-non-covalent-btkis-and-targeted-radiotherapeutics 2026-09-09T15:50:32+00:00 hourly 0.9 https://trial.medpath.com/news/orderlymeds-and-veo-health-partner-to-pair-glp-1-therapies-with-biomarker-testing 2026-09-09T15:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/schrodinger-co-founds-tectora-therapeutics-with-55m-series-a-to-advance-immunology-and-inflammation-programs 2026-09-09T15:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/brain-biotech-receives-eur-11-51-million-milestone-payment-from-royalty-pharma-for-deucrictibant 2026-09-09T15:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/merck-kgaa-s-emd-serono-acquires-postera-s-oral-fertility-programs-targeting-fshr-and-lhcgr 2026-09-09T14:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/why-promising-compounds-still-fail-drug-discovery-shifts-toward-earlier-translatability-testing 2026-09-09T13:49:56+00:00 hourly 0.9 https://trial.medpath.com/news/revvity-to-acquire-human-cell-design-adding-human-pancreatic-beta-cell-models-for-metabolic-drug-discovery 2026-09-09T13:49:53+00:00 hourly 0.9 https://trial.medpath.com/news/solstice-oncology-launches-with-225m-series-a-to-advance-next-generation-ctla-4-antibody-porustobart-in-neoadjuvant-colon-cancer 2026-09-09T12:20:10+00:00 hourly 0.9 https://trial.medpath.com/news/kura-oncology-spins-out-caspian-therapeutics-with-50m-to-develop-menin-inhibitors-for-diabetes 2026-09-09T12:19:17+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-breakthrough-therapy-designation-to-cimzia-for-preventing-adverse-pregnancy-outcomes-in-antiphospholipid-syndrome 2026-09-09T09:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-doses-first-patient-in-phase-2-sjogren-s-trial-of-vav1-degrader-mrt-6160-triggering-50m-payment-to-monte-rosa 2026-09-09T09:48:50+00:00 hourly 0.9 https://trial.medpath.com/news/jst-018-orthopoxvirus-antibody-cocktail-advances-into-first-in-human-phase-1-trial-under-u-s-department-of-war-program 2026-09-09T08:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/redasemtide-clears-ulcer-endpoint-in-dystrophic-eb-but-misses-primary-endpoint-in-global-phase-2-acute-ischemic-stroke-trial 2026-09-09T07:49:01+00:00 hourly 0.9 https://trial.medpath.com/news/western-australia-awards-775000-to-15-precision-medicine-projects-spanning-cancer-alzheimer-s-and-stroke 2026-09-09T06:49:44+00:00 hourly 0.9 https://trial.medpath.com/news/rcp-review-finds-betrayal-of-trust-in-prolonged-temozolomide-prescribing-at-coventry-nhs-trust 2026-09-09T06:49:25+00:00 hourly 0.9 https://trial.medpath.com/news/brandi-glanville-details-multidrug-resistant-infection-and-fungal-ball-diagnosis-ahead-of-surgery 2026-09-09T06:49:23+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-riken-and-ibm-named-finalists-for-2026-acm-gordon-bell-prize-for-quantum-simulation-of-a-12635-atom-protein 2026-09-09T05:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/forus-raises-150m-series-c-at-3b-valuation-to-scale-ai-network-for-medicine-access 2026-09-09T04:50:43+00:00 hourly 0.9 https://trial.medpath.com/news/hae-care-shifts-toward-attack-free-goals-as-experts-outline-when-to-reassess-treatment 2026-09-09T04:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/fda-fills-four-senior-leadership-roles-naming-permanent-directors-for-drugs-vaccines-and-tobacco 2026-09-09T03:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/systematic-review-finds-very-low-certainty-evidence-for-hospital-based-interventions-linking-aud-patients-to-outpatient-care 2026-09-09T02:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/inhibitor-therapeutics-advances-itraconazole-for-gorlin-syndrome-reports-0-265-new-surgically-eligible-bccs-per-patient-year 2026-09-08T23:52:48+00:00 hourly 0.9 https://trial.medpath.com/news/rbqm-delivers-six-to-23-fold-return-on-investment-as-trial-complexity-becomes-the-new-normal 2026-09-08T23:52:15+00:00 hourly 0.9 https://trial.medpath.com/news/horien-wins-three-thai-fda-class-4-approvals-for-regenerative-devices-and-u-s-patent-for-biodegradable-ureteral-stent 2026-09-08T23:52:13+00:00 hourly 0.9 https://trial.medpath.com/news/texas-couple-sentenced-for-smuggling-unapproved-veterinary-drugs-and-pesticides-into-the-u-s 2026-09-08T22:56:50+00:00 hourly 0.9 https://trial.medpath.com/news/family-calls-for-nhs-england-access-to-enhertu-after-woman-dies-of-breast-cancer-at-32 2026-09-08T18:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-drug-ty1-reverses-systemic-sclerosis-effects-in-preclinical-study 2026-09-08T17:49:14+00:00 hourly 0.9 https://trial.medpath.com/news/eppendorf-launches-refrigerated-centrifuge-5811-r-with-sustainable-r290-cooling 2026-09-08T17:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/west-virginia-reports-12-drop-in-drug-overdose-deaths-alongside-declines-in-violent-and-property-crime 2026-09-08T16:51:04+00:00 hourly 0.9 https://trial.medpath.com/news/scibase-receives-additional-order-from-castle-biosciences-to-accelerate-atopic-dermatitis-relapse-prediction-studies 2026-09-08T16:50:44+00:00 hourly 0.9 https://trial.medpath.com/news/global-genes-partners-with-citizen-health-to-power-rare-x-rare-disease-data-platform 2026-09-08T16:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/hcw-biologics-signs-exclusive-distribution-deal-with-akron-biotech-for-car-t-manufacturing-reagent-hcw11-006 2026-09-08T16:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/duane-a-mitchell-named-director-of-the-uf-health-cancer-institute 2026-09-08T15:50:24+00:00 hourly 0.9 https://trial.medpath.com/news/ai-powered-ct-analysis-detects-significant-taladegib-treatment-effects-in-phase-2a-ipf-trial 2026-09-08T15:50:02+00:00 hourly 0.9 https://trial.medpath.com/news/me-therapeutics-advances-in-vivo-cd19-cd22-car-and-liver-detargeted-sting-mrna-programs 2026-09-08T15:49:59+00:00 hourly 0.9 https://trial.medpath.com/news/imdelltra-plus-imfinzi-delivers-landmark-overall-survival-benefit-in-first-line-extensive-stage-small-cell-lung-cancer 2026-09-08T14:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/labcorp-acquires-mlm-medical-labs-becoming-the-only-central-lab-provider-with-a-wholly-owned-network-across-four-continents 2026-09-08T14:50:52+00:00 hourly 0.9 https://trial.medpath.com/news/vapendavir-significantly-reduces-key-inflammatory-biomarkers-in-rhinovirus-challenged-copd-patients 2026-09-08T14:50:51+00:00 hourly 0.9 https://trial.medpath.com/news/orphalan-initiates-global-phase-3-traditional-study-of-once-daily-trientine-in-wilson-disease 2026-09-08T14:50:10+00:00 hourly 0.9 https://trial.medpath.com/news/maxwell-biosciences-mxb-22510-sc-receives-fda-qidp-designation-for-bacterial-and-fungal-pneumonia 2026-09-08T14:50:09+00:00 hourly 0.9 https://trial.medpath.com/news/scinai-ends-pc111-deal-redirects-capital-to-nanoab-platform-and-cdmo-growth 2026-09-08T14:49:48+00:00 hourly 0.9 https://trial.medpath.com/news/veru-advances-oral-sabizabulin-after-preclinical-data-show-potent-activity-in-daraxonrasib-resistant-pancreatic-cancer 2026-09-08T13:51:11+00:00 hourly 0.9 https://trial.medpath.com/news/moonwalk-biosciences-closes-70m-series-b-to-advance-adipose-targeted-rnai-for-obesity 2026-09-08T13:50:48+00:00 hourly 0.9 https://trial.medpath.com/news/accro-bioscience-announces-nmpa-clearance-for-phase-ii-iii-trial-of-ac-201-a-selective-tyk2-jak1-inhibitor-for-non-segmental-vitiligo 2026-09-08T13:49:48+00:00 hourly 0.9 https://trial.medpath.com/news/cloverleaf-bio-raises-33-million-seed-financing-to-advance-engineered-trna-cancer-therapeutics 2026-09-08T12:51:33+00:00 hourly 0.9 https://trial.medpath.com/news/medicare-reconsiders-coverage-of-dcisionrt-raising-stakes-for-precision-medicine-diagnostics 2026-09-08T12:51:13+00:00 hourly 0.9 https://trial.medpath.com/news/welltrust-surpasses-100000-patient-consents-paving-the-way-for-ai-driven-clinical-trial-recruitment 2026-09-08T12:50:45+00:00 hourly 0.9 https://trial.medpath.com/news/johnson-johnson-to-present-phase-3-caplyta-data-across-bipolar-mania-depression-and-schizophrenia-at-psych-congress-2026 2026-09-08T12:50:44+00:00 hourly 0.9 https://trial.medpath.com/news/kiora-pharmaceuticals-appoints-keith-j-lane-as-evp-of-global-clinical-development-and-regulatory-affairs 2026-09-08T12:49:38+00:00 hourly 0.9 https://trial.medpath.com/news/coya-therapeutics-publishes-preclinical-data-showing-complementary-immunomodulatory-effects-of-coya-303-in-neuroinflammation-model 2026-09-08T12:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/pepromene-bio-s-baff-r-car-t-cell-therapy-shows-80-complete-response-rate-in-relapsed-refractory-b-cell-lymphomas 2026-09-08T11:49:30+00:00 hourly 0.9 https://trial.medpath.com/news/egypt-s-eda-wins-who-prequalification-for-drug-quality-control-labs-cementing-maturity-level-3-status 2026-09-08T11:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/quality-over-quantity-specific-car-t-cell-subgroup-may-predict-low-dose-therapy-success 2026-09-08T11:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-shares-plunge-as-del-desiran-misses-primary-endpoint-in-myotonic-dystrophy-trial 2026-09-08T10:51:01+00:00 hourly 0.9 https://trial.medpath.com/news/allergic-rhinoconjunctivitis-market-set-for-evolution-through-2036-as-immunotherapy-access-expands 2026-09-08T09:50:04+00:00 hourly 0.9 https://trial.medpath.com/news/world-first-nitinol-super-elastic-springs-reshape-baby-s-skull-in-craniosynostosis-surgery 2026-09-08T08:50:51+00:00 hourly 0.9 https://trial.medpath.com/news/multi-site-validation-study-confirms-diagnostic-grade-ai-biomarker-detection-from-routine-brightfield-images 2026-09-08T08:50:46+00:00 hourly 0.9 https://trial.medpath.com/news/panntherapi-receives-ansm-approval-to-advance-first-in-class-panx1-targeting-therapy-pti5803-into-phase-2a-in-focal-cortical-dysplasia 2026-09-08T08:50:15+00:00 hourly 0.9 https://trial.medpath.com/news/transgene-and-probiogen-expand-strategic-partnership-with-additional-license-for-age1-cr-pix-cell-line 2026-09-08T07:50:52+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-map-the-enzymatic-route-that-builds-5-azacytidine-in-nature-revealing-a-rare-skeletal-editing-reaction 2026-09-08T07:50:36+00:00 hourly 0.9 https://trial.medpath.com/news/gensight-biologics-advances-gs010-lumevoq-manufacturing-transfer-and-early-access-programs 2026-09-08T07:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/deconstructing-lsd-s-ergoline-core-yields-simplified-compounds-with-reduced-hallucinogenic-and-cardiotoxic-effects 2026-09-08T04:49:14+00:00 hourly 0.9 https://trial.medpath.com/news/biocon-secures-10-year-brazil-supply-contract-for-pertuzumab-in-her2-positive-breast-cancer 2026-09-08T04:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/arm-holdings-ceo-ai-will-help-find-a-cure-for-cancer-within-our-lifetimes 2026-09-08T03:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/tbe-base-editing-therapy-achieves-durable-remission-in-sickle-cell-disease-and-b-thalassemia-across-diverse-genetic-backgrounds 2026-09-08T01:48:44+00:00 hourly 0.9 https://trial.medpath.com/news/uk-pharma-investment-shows-green-shoots-with-ps2bn-committed-but-delivery-will-decide-recovery 2026-09-08T00:52:14+00:00 hourly 0.9 https://trial.medpath.com/news/convicted-murderer-erin-patterson-approved-for-taxpayer-funded-ozempic-in-victorian-prison 2026-09-08T00:52:04+00:00 hourly 0.9 https://trial.medpath.com/news/personalised-risk-adapted-therapy-doubles-six-year-survival-in-high-risk-multiple-myeloma 2026-09-08T00:50:49+00:00 hourly 0.9 https://trial.medpath.com/news/prolight-signs-usd-3-9-million-supply-agreement-with-brainbox-for-tbi-point-of-care-diagnostics 2026-09-08T00:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/community-acquired-bacterial-pneumonia-market-poised-for-expansion-through-2036-amid-rising-antimicrobial-resistance 2026-09-07T19:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/osf-cancer-institute-joins-hoosier-cancer-research-network-to-expand-trial-access-in-central-illinois 2026-09-07T19:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-cancer-drug-cadd522-shows-promise-against-osteoporosis-and-menopause-related-weight-gain 2026-09-07T17:50:58+00:00 hourly 0.9 https://trial.medpath.com/news/vascular-origins-of-alzheimer-s-disease-gain-ground-as-amyloid-hypothesis-faces-mounting-challenges 2026-09-07T17:49:57+00:00 hourly 0.9 https://trial.medpath.com/news/erc-starting-grant-funds-in-vivo-car-t-cell-therapy-using-lipid-nanoparticles-and-genome-editing 2026-09-07T17:49:16+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-supreme-court-rejects-pil-challenging-national-hpv-vaccination-programme 2026-09-07T17:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/aptar-and-aceso-therapeutics-partner-to-advance-inhaled-antisense-oligonucleotide-therapy-for-cystic-fibrosis 2026-09-07T16:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/new-initiative-seeks-500m-to-commercialize-israeli-life-science 2026-09-07T16:49:11+00:00 hourly 0.9 https://trial.medpath.com/news/drug-reconstitution-systems-market-poised-for-growth-through-2035-as-injectable-delivery-advances 2026-09-07T14:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/senate-to-hold-first-ever-congressional-hearing-on-menopause-as-women-s-health-research-funding-lags 2026-09-07T13:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/king-s-college-hospital-recruits-world-s-first-patient-in-phase-3-trial-of-erlitercept-for-lower-risk-mds 2026-09-07T12:48:57+00:00 hourly 0.9 https://trial.medpath.com/news/ibd-s-persistent-unmet-need-durable-remission-and-mucosal-healing-remain-the-missing-piece 2026-09-07T11:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/bi-multispecific-drugs-surge-in-oncology-278-new-candidates-added-in-2024-25 2026-09-07T10:50:51+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-india-to-acquire-pfizer-s-minipress-trademark-for-1250-crore 2026-09-07T10:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/chugai-s-nemolizumab-research-honored-with-11th-jbda-award-for-drug-discovery 2026-09-07T09:49:54+00:00 hourly 0.9 https://trial.medpath.com/news/liverpool-launches-uk-first-ps20m-high-security-robotic-ai-lab-to-accelerate-drug-and-vaccine-discovery 2026-09-07T09:49:19+00:00 hourly 0.9 https://trial.medpath.com/news/sudarshan-pharma-to-acquire-9-5-stake-in-car-t-cell-cdmo-medtherapy-biotechnology 2026-09-07T08:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/bone-marrow-transplant-saves-alabama-boy-with-rare-wiskott-aldrich-syndrome 2026-09-07T08:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/rznomics-reports-major-advances-in-high-efficiency-circular-rna-production 2026-09-07T08:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/louisiana-family-rallies-support-for-foxp1-syndrome-gene-therapy-research 2026-09-07T08:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/nature-reviews-drug-discovery-review-positions-slc-transporters-as-untapped-frontier-in-cns-drug-development 2026-09-07T08:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/ondine-biomedical-partners-with-mexico-s-largest-private-hospital-network-to-pilot-steriwave-nasal-photodisinfection 2026-09-07T08:06:05+00:00 hourly 0.9 https://trial.medpath.com/news/laughter-therapy-eases-breathlessness-in-copd-patients-as-effectively-as-pursed-lip-breathing 2026-09-07T06:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/red-light-therapy-for-skin-aging-modest-evidence-real-risks-and-gaps-in-device-data 2026-09-07T06:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/body-clock-may-speed-surgical-recovery-university-of-auckland-review-finds 2026-09-07T05:49:46+00:00 hourly 0.9 https://trial.medpath.com/news/decade-long-hiring-freeze-leaves-thousands-of-trained-medical-technicians-jobless-in-sindh 2026-09-07T05:49:10+00:00 hourly 0.9 https://trial.medpath.com/news/yonsei-cancer-hospital-expands-carbon-ion-therapy-to-stage-iv-oligometastatic-lung-cancer 2026-09-07T05:49:01+00:00 hourly 0.9 https://trial.medpath.com/news/india-releases-draft-2026-pharmaceutical-patent-examination-guidelines-rebuilding-examiner-toolkit-around-a-decade-of-case-law 2026-09-07T05:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/peripheral-dendritic-cells-prime-cd8-t-cells-in-lymph-nodes-to-drive-tau-mediated-neurodegeneration 2026-09-07T04:49:08+00:00 hourly 0.9 https://trial.medpath.com/news/waterford-family-fights-for-treatment-and-awareness-of-ultra-rare-cacna1e-genetic-disorder 2026-09-07T04:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/sechenov-university-advances-drug-repurposing-via-molecular-docking-for-three-new-indications 2026-09-07T04:49:04+00:00 hourly 0.9 https://trial.medpath.com/news/bubs-australia-secures-permanent-fda-approval-for-three-infant-formula-products-in-us-market 2026-09-07T03:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/hanmi-pharmaceutical-to-fully-deploy-ai-across-quality-assurance-training-on-4000-sops 2026-09-07T03:48:40+00:00 hourly 0.9 https://trial.medpath.com/news/hk-inno-n-s-kepacab-becomes-world-s-first-oral-finished-drug-to-earn-global-epd-certification 2026-09-07T03:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/bbc-presenter-maryam-moshiri-reveals-two-year-battle-with-incurable-blood-cancer-polycythaemia-vera 2026-09-07T02:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/rezubio-announces-fda-and-nmpa-ind-clearances-and-first-cohort-dosing-of-rz-520-a-novel-inhaled-therapy-for-chronic-respiratory-diseases 2026-09-07T02:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/wooree-group-calls-for-scientific-validation-standards-for-liposomal-claims-at-vitafoods-asia-2026 2026-09-07T02:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/peppermint-oil-shows-promise-for-lowering-blood-pressure-in-20-day-clinical-trial 2026-09-07T00:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/il-10-s-dual-role-in-cancer-immunity-review-maps-context-dependent-framework-as-phase-iii-failure-tempers-enthusiasm 2026-09-07T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/clover-reports-positive-phase-2-data-for-rsv-hmpv-piv3-combination-vaccines-in-older-adults 2026-09-06T23:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/acrometa-to-enter-ambient-temperature-cellular-logistics-through-strategic-partnership-with-macro-hrd 2026-09-06T23:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/maternal-age-leaves-a-reversible-genotype-dependent-biological-mark-across-generations 2026-09-06T23:49:01+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-heart-drug-pelacarsen-falls-short-in-trials-challenging-pipeline-strategy 2026-09-06T23:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/arrowhead-pharmaceuticals-director-sells-11600-shares-for-1-million 2026-09-06T23:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/an-evening-for-cure-gala-advances-100m-comprehensive-cancer-center-for-ghana 2026-09-06T19:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/cme-highlights-new-era-in-paediatric-oncology-and-bone-marrow-transplantation 2026-09-06T17:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/osuccc-james-appoints-d-neil-hayes-to-lead-precision-cancer-medicine-institute 2026-09-06T15:50:10+00:00 hourly 0.9 https://trial.medpath.com/news/eyepoint-s-duravyu-misses-primary-endpoint-in-phase-3-lugano-trial-for-wet-amd 2026-09-06T15:49:59+00:00 hourly 0.9 https://trial.medpath.com/news/quaaludes-resurface-decades-after-us-ban-fueled-by-the-wolf-of-wall-street-and-underground-synthesis 2026-09-06T15:49:55+00:00 hourly 0.9 https://trial.medpath.com/news/fresenius-kabi-and-aabb-launch-21st-annual-blood-collectors-week-september-6-12-2026 2026-09-06T15:48:59+00:00 hourly 0.9 https://trial.medpath.com/news/sleep-apnea-strips-nocturnal-vagal-protection-in-type-1-diabetes-during-rem-sleep 2026-09-06T13:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/bioretec-receives-fda-510-k-clearance-for-activascrew-cannulated-com-bioabsorbable-compression-screw 2026-09-06T12:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/ebola-why-children-are-last-to-be-treated-in-medical-crises 2026-09-06T08:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/roivant-and-pulmovant-to-present-phase-2-phocus-data-for-mosliciguat-in-ph-ild-at-ers-2026 2026-09-06T07:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/dianthus-maintains-hold-rating-as-competitor-c1s-faces-cidp-setback-while-claseprubart-advances 2026-09-06T05:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/cat-ownership-at-ages-4-5-linked-to-worse-mental-health-measures-in-children-at-ages-7-8 2026-09-06T02:48:32+00:00 hourly 0.9 https://trial.medpath.com/news/epivax-adds-ai-enabled-enhancements-to-ispri-immunogenicity-risk-platform 2026-09-06T00:48:26+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-first-ever-approval-for-dipg-treatment-as-family-advocacy-fuels-research-momentum 2026-09-05T20:51:42+00:00 hourly 0.9 https://trial.medpath.com/news/patientiq-raises-30m-series-c-to-scale-ehr-integrated-outcomes-intelligence-platform 2026-09-05T20:51:41+00:00 hourly 0.9 https://trial.medpath.com/news/14-people-hospitalized-during-the-chainsmokers-concert-in-san-jose 2026-09-05T20:51:40+00:00 hourly 0.9 https://trial.medpath.com/news/bruce-campbell-shares-five-year-prognosis-amid-battle-with-treatable-incurable-cancer 2026-09-05T20:49:10+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-drug-regulator-flags-counterfeit-abhayrab-rabies-vaccine-batch-after-failed-potency-test 2026-09-05T19:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/nsf-awards-7-9-million-to-establish-vermont-s-pfas-environmental-research-network 2026-09-05T19:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/branded-vs-compounded-glp-1s-a-cost-and-regulatory-comparison-of-wegovy-access-programs 2026-09-05T18:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/lumbar-belts-may-ease-lower-back-pain-and-cut-medication-use-french-trial-finds 2026-09-05T18:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/illicit-anabolic-steroid-lab-uncovered-in-tennessee-home-three-arrested-on-drug-and-child-abuse-charges 2026-09-05T18:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/ovarian-cancer-survivors-highlight-biomarker-testing-and-equity-gaps-for-black-women 2026-09-05T17:48:31+00:00 hourly 0.9 https://trial.medpath.com/news/astrocyte-primary-cilia-emerge-as-a-new-stress-response-target-pointing-to-a-repurposed-ms-drug-for-anxiety-and-depression 2026-09-05T16:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/cohance-lifescience-receives-usfda-form-483-with-four-observations-at-telangana-formulation-plant 2026-09-05T16:48:44+00:00 hourly 0.9 https://trial.medpath.com/news/jubilant-biosys-strengthens-leadership-with-somesh-sharma-as-coo-of-drug-discovery-services 2026-09-05T16:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/singapore-charts-evidence-based-path-to-integrate-traditional-chinese-medicine-into-mainstream-healthcare 2026-09-05T16:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/chimpanzees-once-used-in-hepatitis-b-vaccine-research-receive-long-term-health-checks-in-liberia 2026-09-05T14:50:31+00:00 hourly 0.9 https://trial.medpath.com/news/nigerian-army-pursues-public-private-partnerships-to-modernise-military-healthcare-facilities 2026-09-05T14:49:39+00:00 hourly 0.9 https://trial.medpath.com/news/car-t-therapies-vie-for-historic-first-inclusion-in-china-s-basic-medical-insurance-catalog 2026-09-05T13:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/singapore-bets-350-million-on-geroscience-to-extend-healthspan-nationwide 2026-09-05T12:48:34+00:00 hourly 0.9 https://trial.medpath.com/news/longview-passes-ordinance-criminalizing-child-exposure-to-schedule-i-and-ii-controlled-substances 2026-09-05T11:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/army-doctor-testifies-she-is-investigating-whether-covid-19-vaccines-killed-u-s-troops 2026-09-05T10:48:48+00:00 hourly 0.9 https://trial.medpath.com/news/evinova-and-lothar-medical-partner-to-modernise-respiratory-clinical-trials-with-unified-digital-solution 2026-09-05T09:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-review-finds-ceftriaxone-anaphylaxis-often-presents-without-rash-in-outpatient-settings 2026-09-05T07:50:15+00:00 hourly 0.9 https://trial.medpath.com/news/cellular-quality-control-may-miss-nearly-half-of-certain-misfolded-proteins-raising-disease-risk 2026-09-05T06:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/pemi-launches-women-s-daily-supplement-routine-built-specifically-for-perimenopause 2026-09-05T02:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/voice-disorders-may-be-an-earlier-stronger-sign-of-dementia-than-hearing-loss-large-study-finds 2026-09-05T02:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/defence-therapeutics-receives-first-settlement-under-sharing-agreement-with-sorbie-bornholm 2026-09-04T23:48:28+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-withholds-pennsylvania-s-measles-deaths-from-national-dashboard-amid-political-standoff 2026-09-04T22:54:31+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-pelacarsen-misses-primary-endpoint-in-lp-a-horizon-phase-iii-cardiovascular-outcomes-trial 2026-09-04T21:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-breakthrough-device-designation-to-neola-r-for-continuous-lung-monitoring-in-preterm-infants 2026-09-04T19:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/alleged-lobbying-scandal-surrounds-covid-19-treatment-trial-approval-as-genencell-investment-value-evaporates 2026-09-04T18:49:25+00:00 hourly 0.9 https://trial.medpath.com/news/justice-minister-nominee-reported-to-police-over-alleged-lobbying-of-covid-19-drug-trial-approval 2026-09-04T18:49:13+00:00 hourly 0.9 https://trial.medpath.com/news/sheffield-honours-cecil-george-paine-pioneer-of-penicillin-s-therapeutic-use 2026-09-04T17:48:44+00:00 hourly 0.9 https://trial.medpath.com/news/brain-implant-trials-raise-unresolved-questions-about-post-trial-device-access 2026-09-04T17:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/hidalgo-county-deploys-five-free-naloxone-vending-machines-to-expand-overdose-antidote-access 2026-09-04T16:51:11+00:00 hourly 0.9 https://trial.medpath.com/news/hair-based-testing-unlocks-a-molecular-movie-of-environmental-exposures 2026-09-04T16:49:11+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-sec-recommends-phase-3-trial-waiver-for-roche-s-subcutaneous-ocrelizumab-in-multiple-sclerosis 2026-09-04T16:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/nature-methods-publication-reveals-single-molecule-tau-proteoform-insights-for-alzheimer-s-disease 2026-09-04T14:49:25+00:00 hourly 0.9 https://trial.medpath.com/news/nice-recommends-merck-s-ezmekly-mirdametinib-for-children-as-young-as-two-with-nf1-related-plexiform-neurofibromas 2026-09-04T14:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/autoimmune-diseases-form-distinct-genetic-clusters-rather-than-sharing-a-single-common-basis-swedish-registry-study-finds 2026-09-04T14:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/thryv-therapeutics-licenses-structurally-distinct-sgk1-inhibitors-to-expand-into-parkinson-s-and-alzheimer-s-disease 2026-09-04T13:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/lung-cancer-patients-show-higher-microplastic-burden-in-lungs-study-finds 2026-09-04T13:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/tangram-s-tgm-312-advances-to-mash-patient-cohorts-in-phase-1-2-restore-mash-trial 2026-09-04T12:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/acepodia-s-gpc3-targeted-dual-payload-adc-ace723-clears-fda-ind-for-hepatocellular-carcinoma 2026-09-04T12:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/drug-resistant-fungus-trichophyton-indotineae-spreads-to-29-countries-cases-surge-sevenfold 2026-09-04T09:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/fda-warns-fresenius-over-leaking-sterile-dialysis-bags-and-cgmp-failures-at-ogden-plant 2026-09-04T09:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/menopause-is-missing-from-most-electronic-health-records-undermining-women-s-health-research 2026-09-04T07:50:29+00:00 hourly 0.9 https://trial.medpath.com/news/unmc-marks-10-years-of-car-t-cell-therapy-innovation 2026-09-04T06:43:32+00:00 hourly 0.9 https://trial.medpath.com/news/alphagenome-atlas-maps-molecular-effects-of-all-9-billion-possible-human-dna-variants 2026-09-04T06:41:49+00:00 hourly 0.9 https://trial.medpath.com/news/canada-s-drug-agency-recommends-conditional-reimbursement-for-yorvipath-in-chronic-hypoparathyroidism 2026-09-04T06:39:53+00:00 hourly 0.9 https://trial.medpath.com/news/genetically-edited-pig-kidney-sustains-patient-for-record-271-days-serving-as-first-bridge-to-human-transplant 2026-09-04T06:39:41+00:00 hourly 0.9 https://trial.medpath.com/news/patient-derived-organoid-screen-identifies-triple-drug-combination-against-liver-cancer 2026-09-04T06:39:01+00:00 hourly 0.9 https://trial.medpath.com/news/nyxoah-s-acccess-trial-meets-co-primary-endpoints-for-genio-in-complex-sleep-apnea-patients 2026-09-04T06:38:41+00:00 hourly 0.9 https://trial.medpath.com/news/eclincloud-surpasses-1100-clinical-trials-as-its-unified-ai-driven-platform-expands-across-10-countries 2026-09-04T06:38:25+00:00 hourly 0.9 https://trial.medpath.com/news/2026-ig-nobel-prizes-honor-cockroach-milk-chemistry-and-a-cross-species-definition-of-kissing 2026-09-04T06:38:02+00:00 hourly 0.9 https://trial.medpath.com/news/psilocybin-prevents-chemotherapy-induced-peripheral-neuropathy-in-preclinical-models-paving-the-way-for-a-phase-2-trial 2026-09-04T06:37:10+00:00 hourly 0.9 https://trial.medpath.com/news/markel-launches-travel-reimbursement-scheme-to-boost-rare-disease-trial-enrollment 2026-09-04T06:37:09+00:00 hourly 0.9 https://trial.medpath.com/news/kkr-to-sell-minority-stake-in-nordic-bioscience-to-founder-claus-christiansen 2026-09-04T06:31:51+00:00 hourly 0.9 https://trial.medpath.com/news/persevere-therapeutics-appoints-james-barlow-to-board-as-myc-inhibitor-misetionamide-enters-phase-2 2026-09-04T06:30:20+00:00 hourly 0.9 https://trial.medpath.com/news/celularity-and-musecell-innovations-strike-new-jersey-manufacturing-deal-worth-up-to-300-million 2026-09-04T06:30:18+00:00 hourly 0.9 https://trial.medpath.com/news/peptide-microdroplets-deliver-sirna-to-cut-colorectal-tumor-growth-by-67-in-mice 2026-09-04T06:30:17+00:00 hourly 0.9 https://trial.medpath.com/news/faa-proposes-easing-medical-certification-rules-for-pilots-with-non-insulin-dependent-diabetes 2026-09-04T06:28:45+00:00 hourly 0.9 https://trial.medpath.com/news/fda-seeks-public-input-to-advance-botanical-drug-product-development 2026-09-04T06:28:31+00:00 hourly 0.9 https://trial.medpath.com/news/eight-year-multimuther-study-reveals-individual-molecular-aging-trajectories-diverge-from-population-patterns 2026-09-04T06:28:17+00:00 hourly 0.9 https://trial.medpath.com/news/regenicin-advances-autologous-cultured-skin-substitute-tiscela-toward-fda-clinical-trials-for-severe-burns 2026-09-04T06:25:03+00:00 hourly 0.9 https://trial.medpath.com/news/resonant-clinical-solutions-acquires-creapharm-bioservices-to-expand-cryogenic-storage-and-advanced-therapy-capabilities 2026-09-04T06:24:39+00:00 hourly 0.9 https://trial.medpath.com/news/family-offices-quietly-power-biotech-s-funding-comeback-backing-gene-therapy-and-ai-driven-drug-discovery 2026-09-04T06:23:57+00:00 hourly 0.9 https://trial.medpath.com/news/cellipont-bioservices-texas-facility-advances-six-cell-therapy-programs-toward-ind-submission-in-2026 2026-09-04T06:23:33+00:00 hourly 0.9 https://trial.medpath.com/news/nexalin-s-item-level-adas-cog-analysis-reveals-domain-specific-cognitive-gains-in-alzheimer-s-trial 2026-09-04T06:22:39+00:00 hourly 0.9 https://trial.medpath.com/news/northway-biotech-opens-first-baltic-cell-therapy-and-personalized-medicine-cdmo-in-vilnius 2026-09-04T06:21:07+00:00 hourly 0.9 https://trial.medpath.com/news/biological-age-and-longevity-diagnostics-market-projected-to-reach-5-58-billion-by-2030 2026-09-04T06:21:02+00:00 hourly 0.9 https://trial.medpath.com/news/i-m-greentm-bio-based-polymer-helps-deterra-r-drug-disposal-pouch-win-multiple-packaging-industry-awards 2026-09-04T06:20:13+00:00 hourly 0.9 https://trial.medpath.com/news/frost-sullivan-2026-blue-book-charts-hong-kong-18a-biotech-sector-s-shift-toward-value-driven-growth 2026-09-04T06:20:12+00:00 hourly 0.9 https://trial.medpath.com/news/university-of-oxford-and-2u-launch-ai-in-drug-discovery-and-medicine-programme 2026-09-04T06:20:00+00:00 hourly 0.9 https://trial.medpath.com/news/lumirix-r-ruxolitinib-phosphate-cream-approved-in-china-for-mild-to-moderate-atopic-dermatitis 2026-09-04T06:19:38+00:00 hourly 0.9 https://trial.medpath.com/news/armata-publishes-near-atomic-structural-atlas-of-pseudomonas-phage-ar-km-illuminating-genome-ejection-mechanism 2026-09-04T06:18:52+00:00 hourly 0.9 https://trial.medpath.com/news/medicus-pharma-secures-global-license-from-pfizer-for-cd228-targeting-adc-valued-at-over-1-billion-in-milestones 2026-09-04T06:16:23+00:00 hourly 0.9 https://trial.medpath.com/news/targeting-kv7-4-channels-could-delay-preterm-birth-preclinical-study-finds 2026-09-04T06:15:39+00:00 hourly 0.9 https://trial.medpath.com/news/healthcare-experts-call-for-regulatory-reforms-to-advance-precision-medicine-and-patient-care-in-south-korea 2026-09-04T06:15:32+00:00 hourly 0.9 https://trial.medpath.com/news/fangzhou-s-ai-powered-chronic-care-model-named-to-fortune-china-s-best-designs-2026 2026-09-04T06:15:07+00:00 hourly 0.9 https://trial.medpath.com/news/personalised-medicine-shows-early-success-in-preventing-kidney-injury-after-major-surgery 2026-09-04T06:14:41+00:00 hourly 0.9 https://trial.medpath.com/news/superluminal-medicines-raises-60m-series-b-to-advance-mc4r-agonist-for-rare-genetic-obesity-into-the-clinic 2026-09-04T06:10:56+00:00 hourly 0.9 https://trial.medpath.com/news/idbs-advances-drug-development-with-polar-platform-innovations-and-ai-investments-in-2025 2026-09-04T06:10:31+00:00 hourly 0.9 https://trial.medpath.com/news/fda-s-science-based-crackdown-on-unproven-stem-cell-clinics-marks-a-surprising-regulatory-bright-spot 2026-09-04T06:10:23+00:00 hourly 0.9 https://trial.medpath.com/news/cytosorb-cuts-severe-bleeding-by-37-in-urgent-cabg-patients-on-ticagrelor-real-world-data-show 2026-09-04T06:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/aspen-s-mounjaro-sales-hit-r1-5-billion-as-it-readies-generic-semaglutide-push-across-africa 2026-09-04T06:06:46+00:00 hourly 0.9 https://trial.medpath.com/news/ai-designed-protein-vehicles-outperform-lipid-nanoparticles-for-rna-and-crispr-delivery 2026-09-04T06:06:30+00:00 hourly 0.9 https://trial.medpath.com/news/asia-bio-partnering-forum-2026-data-ai-and-platform-intelligence-reshape-how-apac-biotechs-are-valued 2026-09-04T06:06:13+00:00 hourly 0.9 https://trial.medpath.com/news/systemic-antifungal-fluconazole-may-ease-ibd-disease-activity-by-restoring-gut-microbiome 2026-09-04T06:04:33+00:00 hourly 0.9 https://trial.medpath.com/news/encoded-therapeutics-etx101-gene-therapy-shows-durable-seizure-reduction-and-neurodevelopmental-gains-in-dravet-syndrome 2026-09-04T06:03:05+00:00 hourly 0.9 https://trial.medpath.com/news/community-pharmacists-perceived-barriers-and-drivers-toward-vaccination-services-in-saudi-arabia 2026-09-04T06:02:04+00:00 hourly 0.9 https://trial.medpath.com/news/sec-and-fda-sign-memorandum-of-understanding-to-share-information-on-fda-regulated-products 2026-09-04T05:59:31+00:00 hourly 0.9 https://trial.medpath.com/news/ncrha-reforms-patient-escort-and-hospital-attendant-services-after-review-uncovers-alleged-gang-activity-and-widespread-misconduct 2026-09-04T05:59:16+00:00 hourly 0.9 https://trial.medpath.com/news/huge-gwas-links-over-1200-genetic-variants-to-the-big-five-personality-traits 2026-09-04T05:58:39+00:00 hourly 0.9 https://trial.medpath.com/news/global-mpox-vaccine-stockpile-launched-to-strengthen-equitable-outbreak-response 2026-09-04T05:56:25+00:00 hourly 0.9 https://trial.medpath.com/news/barda-exercises-36-9-million-option-to-stockpile-cefiderocol-a-last-resort-antibiotic-for-drug-resistant-gram-negative-infections 2026-09-04T05:55:05+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-opens-two-new-research-buildings-in-largest-research-investment-in-its-history 2026-09-04T05:54:34+00:00 hourly 0.9 https://trial.medpath.com/news/multicellular-3d-tumor-spheroids-emerge-as-a-predictive-bridge-between-2d-assays-and-solid-tumors-in-preclinical-drug-testing 2026-09-02T21:50:05+00:00 hourly 0.9 https://trial.medpath.com/news/two-scientists-win-2026-horwitz-prize-for-rett-syndrome-breakthrough 2026-09-02T21:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/mito-health-passes-one-million-lab-tests-expands-into-seven-preventive-testing-categories 2026-09-02T21:48:33+00:00 hourly 0.9 https://trial.medpath.com/news/450-nurses-to-strike-at-west-anaheim-medical-center-over-patient-care-and-staffing-concerns 2026-09-02T21:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-launches-overdose-prevention-data-channel-amid-12-3-decline-in-drug-overdose-deaths 2026-09-02T20:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/labradoodle-s-persistent-sniffing-leads-to-early-melanoma-diagnosis-in-chicago-heights-woman 2026-09-02T19:50:41+00:00 hourly 0.9 https://trial.medpath.com/news/smt-launches-safe-pfo-trial-first-head-to-head-comparison-of-cocoon-and-amplatzer-pfo-closure-devices 2026-09-02T19:49:48+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-ub-hwi-s-national-crystallization-center-5-5-million-to-advance-structural-biology 2026-09-02T19:49:47+00:00 hourly 0.9 https://trial.medpath.com/news/altria-sues-fda-to-overhaul-tobacco-product-review-system 2026-09-02T19:49:32+00:00 hourly 0.9 https://trial.medpath.com/news/china-approves-mprosevir-the-world-s-first-ai-and-del-discovered-covid-19-drug 2026-09-02T18:49:14+00:00 hourly 0.9 https://trial.medpath.com/news/waterfall-scientific-awarded-up-to-54-5-million-from-arpa-h-to-lead-continuous-flow-mrna-manufacturing-consortium 2026-09-02T18:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/adjunctive-lumateperone-improves-sexual-function-in-mdd-patients-with-inadequate-antidepressant-response 2026-09-02T17:50:57+00:00 hourly 0.9 https://trial.medpath.com/news/cencora-launches-cell-and-gene-therapy-enablement-to-help-health-systems-build-and-scale-cgt-programs 2026-09-02T17:49:35+00:00 hourly 0.9 https://trial.medpath.com/news/world-s-first-dedicated-smoking-cessation-guidelines-for-type-2-diabetes-released-by-global-experts 2026-09-02T17:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/formosa-pharmaceuticals-targets-first-adc-biosimilar-launch-in-us-and-europe-with-tsy-110 2026-09-02T16:51:24+00:00 hourly 0.9 https://trial.medpath.com/news/onymos-and-vanta-diagnostics-report-ai-assisted-lab-intake-boosts-efficiency-by-72-and-cuts-errors-by-40 2026-09-02T16:50:56+00:00 hourly 0.9 https://trial.medpath.com/news/iss-national-lab-reaches-1000-payload-milestone-as-casis-marks-15-years-of-space-based-r-d-leadership 2026-09-02T16:50:55+00:00 hourly 0.9 https://trial.medpath.com/news/multi-modality-analytical-strategies-aim-to-overcome-bottlenecks-in-next-gen-cell-and-gene-therapy-development 2026-09-02T16:50:53+00:00 hourly 0.9 https://trial.medpath.com/news/treeline-and-roche-collaborate-on-phase-1-trial-of-bcl6-degrader-tln-121-combined-with-cd20xcd3-bispecifics-in-b-cell-lymphomas 2026-09-02T16:50:26+00:00 hourly 0.9 https://trial.medpath.com/news/lifecore-biomedical-signs-commercial-transfer-agreement-for-marketed-injectable-product 2026-09-02T16:50:23+00:00 hourly 0.9 https://trial.medpath.com/news/switzerland-to-boost-funding-and-establish-a-national-register-for-rare-diseases 2026-09-02T16:50:21+00:00 hourly 0.9 https://trial.medpath.com/news/ubs-lifts-j-j-price-target-to-320-on-oncology-and-immunology-growth-outlook 2026-09-02T16:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/tumor-associated-macrophages-emerge-as-central-drivers-of-gastric-cancer-peritoneal-metastasis-and-immunotherapy-resistance 2026-09-02T15:51:47+00:00 hourly 0.9 https://trial.medpath.com/news/caris-life-sciences-to-present-seven-precision-oncology-studies-at-iaslc-2026-world-conference-on-lung-cancer 2026-09-02T15:50:03+00:00 hourly 0.9 https://trial.medpath.com/news/purple-biotech-secures-u-s-patent-allowance-for-captn-3-tri-specific-antibody-platform 2026-09-02T15:50:02+00:00 hourly 0.9 https://trial.medpath.com/news/bioaffinity-technologies-advances-cypath-lung-into-post-treatment-lung-cancer-surveillance 2026-09-02T15:49:49+00:00 hourly 0.9 https://trial.medpath.com/news/fortrea-to-acquire-early-phase-services-from-worldwide-clinical-trials-in-45m-deal 2026-09-02T15:49:45+00:00 hourly 0.9 https://trial.medpath.com/news/bayesian-health-s-fda-cleared-ai-sepsis-monitor-wins-first-medicare-ntap-reimbursement-pathway 2026-09-02T15:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/rna-polymerase-accurately-transcribes-an-eight-letter-genetic-alphabet-expanding-synthetic-biology 2026-09-02T15:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/qualcomm-and-asus-launch-on-premises-pharmaceutical-ai-agent-for-community-pharmacies-in-southern-taiwan 2026-09-02T14:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/cmc-bottleneck-is-choking-biopharma-s-drug-pipeline-says-zifo 2026-09-02T14:48:26+00:00 hourly 0.9 https://trial.medpath.com/news/benchsci-and-argenx-sign-two-year-enterprise-agreement-to-deploy-ai-driven-preclinical-drug-discovery-platform 2026-09-02T14:48:20+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-first-gene-therapy-clinical-trial-for-ultra-rare-pediatric-neurodegenerative-disease-mliv 2026-09-02T13:51:26+00:00 hourly 0.9 https://trial.medpath.com/news/mizzou-researchers-uncover-promising-new-target-for-treating-high-blood-pressure 2026-09-02T13:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/fda-adds-boxed-warning-to-injectafer-for-risk-of-symptomatic-hypophosphatemia 2026-09-02T13:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/raziel-and-fosun-report-positive-phase-3-results-for-rzl-012-in-submental-fat-reduction-paving-path-to-china-nda 2026-09-02T13:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/evotec-and-plectonic-partner-to-develop-logic-gated-t-cell-engagers-for-solid-tumors 2026-09-02T12:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/repatha-sales-surge-37-to-953-million-as-amgen-s-overlooked-cardiovascular-growth-driver-gains-momentum 2026-09-02T11:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/braveheart-bio-to-present-at-cantor-global-healthcare-conference-as-it-advances-bhb-1893-for-hypertrophic-cardiomyopathy 2026-09-02T11:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/neuropace-to-present-rns-system-at-cantor-and-wells-fargo-healthcare-conferences 2026-09-02T11:48:32+00:00 hourly 0.9 https://trial.medpath.com/news/medipost-recruits-samsung-biologics-veteran-min-ho-sung-to-lead-cartistem-s-global-expansion 2026-09-02T10:49:44+00:00 hourly 0.9 https://trial.medpath.com/news/blood-cancer-united-launches-2026-light-the-night-season-to-advance-blood-cancer-research-and-support 2026-09-02T10:12:00+00:00 hourly 0.9 https://trial.medpath.com/news/bc-platforms-launches-bc-mosaic-app-store-to-empower-data-scientists-and-healthcare-researchers 2026-09-02T09:49:18+00:00 hourly 0.9 https://trial.medpath.com/news/newbiologix-and-synastra-partner-to-advance-stable-raav-manufacturing-for-duchenne-muscular-dystrophy-gene-therapy 2026-09-02T09:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/unist-blood-filtering-technology-aims-to-block-cancer-metastasis-before-it-begins 2026-09-02T09:02:00+00:00 hourly 0.9 https://trial.medpath.com/news/desiccant-closures-market-to-reach-usd-937-2-million-by-2036-as-integrated-moisture-control-reshapes-pharmaceutical-packaging 2026-09-02T06:48:30+00:00 hourly 0.9 https://trial.medpath.com/news/bioversys-granted-fda-fast-track-designation-for-bv100-in-carbapenem-resistant-acinetobacter-pneumonia 2026-09-02T05:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/weight-loss-supplement-recalled-after-fda-finds-undeclared-fluoxetine-and-toxic-dnp 2026-09-02T05:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/idt-and-ansa-biotechnologies-expand-partnership-to-streamline-access-to-complex-dna-constructs 2026-09-02T03:57:50+00:00 hourly 0.9 https://trial.medpath.com/news/vitrafy-life-sciences-enters-us-cell-and-gene-therapy-market-with-cryopreservation-agreement 2026-09-02T03:56:51+00:00 hourly 0.9 https://trial.medpath.com/news/ono-pharma-partners-with-aitia-to-use-causal-ai-digital-twins-for-neurological-drug-discovery 2026-09-02T02:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/rutgers-led-team-identifies-36-genes-tied-to-ocd-and-tic-disorders-opening-new-treatment-targets 2026-09-02T00:50:58+00:00 hourly 0.9 https://trial.medpath.com/news/idsa-and-hivma-warn-proposed-niaid-restructuring-threatens-u-s-infectious-disease-research-and-hiv-response 2026-09-01T23:52:51+00:00 hourly 0.9 https://trial.medpath.com/news/study-identifies-risk-groups-for-ketoacidosis-a-severe-side-effect-of-sglt2-inhibitors 2026-09-01T23:52:51+00:00 hourly 0.9 https://trial.medpath.com/news/collplant-acquires-lightsolver-to-enter-photonic-computing-market 2026-09-01T23:52:49+00:00 hourly 0.9 https://trial.medpath.com/news/scopia-surgical-raises-c-2-65-million-to-build-ai-gps-for-robotic-surgery 2026-09-01T23:51:43+00:00 hourly 0.9 https://trial.medpath.com/news/leukemia-research-foundation-funds-uc-study-targeting-rhoa-in-tp53-mutated-aml 2026-09-01T22:55:44+00:00 hourly 0.9 https://trial.medpath.com/news/systech-launches-traceiq-an-ai-powered-traceability-platform-for-pharmaceutical-supply-chains 2026-09-01T22:54:07+00:00 hourly 0.9 https://trial.medpath.com/news/uc-davis-health-launches-pediatric-cardiology-and-hospital-medicine-fellowships-to-address-subspecialist-shortages 2026-09-01T21:54:20+00:00 hourly 0.9 https://trial.medpath.com/news/stryker-wins-fda-de-novo-authorization-for-first-surgical-app-on-apple-vision-pro-completes-first-hip-arthroscopy 2026-09-01T20:54:22+00:00 hourly 0.9 https://trial.medpath.com/news/novo-nordisk-reshuffles-r-d-leadership-as-andrea-haegebarth-joins-to-lead-global-research 2026-09-01T20:52:38+00:00 hourly 0.9 https://trial.medpath.com/news/skinmedica-launches-barrier-calming-cream-to-support-regenerative-skincare-and-skin-barrier-health 2026-09-01T18:49:49+00:00 hourly 0.9 https://trial.medpath.com/news/blood-cancer-treatment-advances-have-saved-nearly-26-million-years-of-life-over-75-years 2026-09-01T18:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/medincell-appoints-edna-venneker-md-as-chief-medical-officer 2026-09-01T18:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/simcere-zaiming-licenses-tri-specific-antibody-sim0660-to-roche-in-deal-worth-up-to-1-53-billion 2026-09-01T18:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/n-power-medicine-closes-32-million-series-b-to-expand-community-oncology-network-and-proeca-platform 2026-09-01T18:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/bighat-s-ai-designed-cdh17-antibody-drug-conjugate-bhb810-enters-first-in-human-trial-for-gastric-cancer 2026-09-01T17:50:15+00:00 hourly 0.9 https://trial.medpath.com/news/chfa-names-eight-emerging-canadian-wellness-brands-as-finalists-for-2026-launch-pad-competition 2026-09-01T17:18:00+00:00 hourly 0.9 https://trial.medpath.com/news/mizzou-researchers-pursue-first-drug-treatment-for-aortic-valve-calcification-targeting-dock2 2026-09-01T16:51:28+00:00 hourly 0.9 https://trial.medpath.com/news/immunic-appoints-chitrang-dave-as-chief-data-and-digital-officer-ahead-of-pivotal-ms-readouts 2026-09-01T16:51:05+00:00 hourly 0.9 https://trial.medpath.com/news/u-s-bill-proposes-12-year-market-exclusivity-for-fda-approved-botanical-drugs 2026-09-01T16:50:57+00:00 hourly 0.9 https://trial.medpath.com/news/children-s-hospital-colorado-launches-sublingual-immunotherapy-program-for-pediatric-food-allergies 2026-09-01T16:50:14+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-breakthrough-therapy-designation-to-juniper-s-jbs-003-hypoxia-tracer-for-radiation-de-escalation-in-hpv-positive-oropharyngeal-cancer 2026-09-01T15:49:29+00:00 hourly 0.9 https://trial.medpath.com/news/md-integrations-partners-with-legitscript-to-expedite-telehealth-compliance-certification 2026-09-01T15:49:01+00:00 hourly 0.9 https://trial.medpath.com/news/bioviva-secures-two-u-s-patents-for-longevity-gene-therapies-targeting-klotho-htert-and-follistatin-344 2026-09-01T15:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/stolen-veterinary-euthanasia-drug-poses-extreme-danger-to-maine-community-police-warn 2026-09-01T13:49:43+00:00 hourly 0.9 https://trial.medpath.com/news/veeva-falcon-safety-automates-adverse-event-intake-across-e2b-compliant-systems 2026-09-01T13:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/early-onset-bowel-cancer-shows-distinct-biology-and-better-survival-in-liver-only-metastases 2026-09-01T13:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/protagonist-therapeutics-trades-63-below-estimated-fair-value-despite-elevated-p-e-analyst-model-shows 2026-09-01T13:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/netramark-appoints-veteran-pharmaceutical-executive-dr-keith-fournier-to-board-of-directors 2026-09-01T12:52:57+00:00 hourly 0.9 https://trial.medpath.com/news/south-korea-expands-health-insurance-to-cut-costs-for-rare-diseases-and-severe-diabetes 2026-09-01T10:53:39+00:00 hourly 0.9 https://trial.medpath.com/news/optiscan-launches-us-head-and-neck-cancer-imaging-study-with-mayo-clinic-to-support-fda-submissions 2026-09-01T09:25:24+00:00 hourly 0.9 https://trial.medpath.com/news/fujirebio-secures-health-canada-licenses-for-blood-based-neurology-assays 2026-09-01T09:24:59+00:00 hourly 0.9 https://trial.medpath.com/news/immediate-coronary-angiography-does-not-improve-survival-after-out-of-hospital-cardiac-arrest-without-st-elevation 2026-09-01T09:19:06+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-johnson-johnson-s-imaavy-nipocalimab-aahu-as-first-therapy-for-warm-autoimmune-hemolytic-anemia 2026-09-01T09:16:17+00:00 hourly 0.9 https://trial.medpath.com/news/long-term-phase-3-baxhtn-data-confirm-baxdrostat-efficacy-and-safety-in-resistant-hypertension 2026-09-01T09:15:00+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-bristol-myers-pause-autoimmune-car-t-trials-after-inflammatory-safety-signals 2026-09-01T09:14:37+00:00 hourly 0.9 https://trial.medpath.com/news/senate-unanimously-passes-kay-hagan-tick-reauthorization-act-as-lyme-cases-hit-record-highs 2026-09-01T05:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/teva-and-trump-administration-announce-intent-to-reach-agreement-on-affordable-medicines-and-supply-chain-security-for-u-s-medicaid-patients 2026-08-31T21:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/inventiva-appoints-chris-benecchi-as-chief-operating-officer-ahead-of-pivotal-mash-phase-3-readout 2026-08-31T21:48:32+00:00 hourly 0.9 https://trial.medpath.com/news/arsenalbio-shifts-strategic-focus-to-in-vivo-car-t-cell-therapies-expanding-into-autoimmunity 2026-08-31T21:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-drug-shortages-threaten-lives-as-efforts-to-prevent-them-hit-regulatory-red-tape 2026-08-31T20:53:34+00:00 hourly 0.9 https://trial.medpath.com/news/chile-s-isp-opens-public-consultation-on-national-technovigilance-system-guidance-for-medical-devices 2026-08-31T20:53:33+00:00 hourly 0.9 https://trial.medpath.com/news/new-aan-and-ahs-guidelines-expand-pharmacological-options-for-migraine-prevention 2026-08-31T20:52:53+00:00 hourly 0.9 https://trial.medpath.com/news/australia-prepares-world-first-mrna-vaccine-trial-for-children-with-aggressive-brain-tumors 2026-08-31T20:52:43+00:00 hourly 0.9 https://trial.medpath.com/news/two-week-wearable-heart-monitor-after-unexplained-fainting-doubles-arrhythmia-detection-and-halves-one-year-death-rate 2026-08-31T20:52:16+00:00 hourly 0.9 https://trial.medpath.com/news/karolinska-institutet-s-center-for-heart-failure-and-arrhythmia-publishes-broad-2026-research-portfolio-spanning-epidemiology-pharmacotherapy-and-outcomes 2026-08-31T20:51:21+00:00 hourly 0.9 https://trial.medpath.com/news/australia-s-little-penguin-h5n1-vaccination-drive-uses-killed-virus-shot-not-mrna-officials-confirm 2026-08-31T18:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/drug-repurposing-screen-identifies-dopamine-signaling-and-cox-inhibition-as-candidate-therapeutic-pathways-for-piga-cdg 2026-08-31T18:49:16+00:00 hourly 0.9 https://trial.medpath.com/news/trump-expected-to-announce-new-drug-pricing-deals-with-nearly-a-dozen-drugmakers 2026-08-31T18:48:50+00:00 hourly 0.9 https://trial.medpath.com/news/anonymous-donor-establishes-endowed-funds-to-advance-concussion-care-and-research-at-stony-brook-medicine 2026-08-31T18:48:49+00:00 hourly 0.9 https://trial.medpath.com/news/federal-circuit-upholds-cabozantinib-crystalline-salt-patents-preserving-exelixis-market-exclusivity-to-2030 2026-08-31T18:48:44+00:00 hourly 0.9 https://trial.medpath.com/news/abbott-launches-first-ready-to-feed-infant-formula-made-with-whole-milk-in-the-u-s 2026-08-31T17:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/how-to-read-a-biotech-clinical-trial-result-p-values-endpoints-and-investor-implications 2026-08-31T16:52:08+00:00 hourly 0.9 https://trial.medpath.com/news/lilly-s-taltz-plus-zepbound-shows-durable-one-year-benefits-in-psoriatic-disease-and-obesity 2026-08-31T16:50:35+00:00 hourly 0.9 https://trial.medpath.com/news/veloxis-doses-first-patient-in-phase-2-rengevity-201-trial-of-pegrizeprument-for-kidney-transplant-rejection-prevention 2026-08-31T16:49:10+00:00 hourly 0.9 https://trial.medpath.com/news/biotecanada-announces-2026-gold-leaf-award-winners-recognizing-excellence-across-canada-s-biotechnology-ecosystem 2026-08-31T15:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/fareon-links-microtesla-magnetic-therapy-to-reduced-brain-age-and-repair-biomarkers-in-long-covid-cognitive-impairment 2026-08-31T15:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/oligomerix-appoints-cara-cassino-m-d-as-interim-president-and-ceo-to-advance-olx-07010-in-alzheimer-s-disease 2026-08-31T15:48:34+00:00 hourly 0.9 https://trial.medpath.com/news/emmaus-life-sciences-cedars-sinai-sign-option-deal-to-advance-l-glutamine-in-pancreatic-cancer-after-phase-1-tumor-shrinkage-data 2026-08-31T15:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/meta-analysis-of-397-pediatric-mental-health-trials-finds-women-minoritized-groups-systematically-under-represented 2026-08-31T14:51:37+00:00 hourly 0.9 https://trial.medpath.com/news/one-year-exercise-intervention-cuts-atrial-fibrillation-burden-by-45-in-nexaf-trial 2026-08-31T14:51:06+00:00 hourly 0.9 https://trial.medpath.com/news/angptl3-inhibitors-market-poised-to-reach-3-48-billion-by-2035-as-pipeline-diversifies-beyond-monoclonal-antibodies 2026-08-31T14:50:44+00:00 hourly 0.9 https://trial.medpath.com/news/cymbiotika-partners-with-hundred-health-to-deliver-personalized-biomarker-driven-wellness-plans 2026-08-31T14:50:13+00:00 hourly 0.9 https://trial.medpath.com/news/national-conference-on-quantum-biotechnology-charts-india-s-path-in-quantum-enabled-life-sciences 2026-08-31T14:49:56+00:00 hourly 0.9 https://trial.medpath.com/news/routine-invasive-treatment-should-not-be-replaced-by-selective-care-in-older-nstemi-patients-evaold-trial-finds 2026-08-31T14:49:54+00:00 hourly 0.9 https://trial.medpath.com/news/xyra-doses-first-european-patient-in-phase-2-3-harbor-af-study-of-budiodarone-for-atrial-fibrillation 2026-08-31T13:50:35+00:00 hourly 0.9 https://trial.medpath.com/news/cipla-secures-exclusive-rights-to-her2-bispecific-adc-tqb2102-across-seven-emerging-markets 2026-08-31T13:50:19+00:00 hourly 0.9 https://trial.medpath.com/news/redhill-acquires-commercialization-rights-to-ferring-s-rebyota-and-clenpiq-in-transformational-gi-repositioning 2026-08-31T13:49:17+00:00 hourly 0.9 https://trial.medpath.com/news/acto-ceo-parth-khanna-ai-trust-in-pharma-comes-down-to-compliant-plus-capable 2026-08-31T13:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/beyond-air-receives-fda-breakthrough-device-designation-for-lungfit-go-in-ntm-pd 2026-08-31T13:49:10+00:00 hourly 0.9 https://trial.medpath.com/news/eli-lilly-to-acquire-merida-biosciences-for-up-to-2-88-billion-adding-novel-autoantibody-targeting-pipeline 2026-08-31T12:52:35+00:00 hourly 0.9 https://trial.medpath.com/news/esc-issues-first-dedicated-international-guidelines-on-cardiac-rehabilitation 2026-08-31T12:36:00+00:00 hourly 0.9 https://trial.medpath.com/news/ugandan-firm-dei-biopharma-files-seven-us-patents-for-mrna-cancer-vaccines-targeting-recurrence 2026-08-31T12:32:19+00:00 hourly 0.9 https://trial.medpath.com/news/labcorp-launches-next-generation-of-global-trial-connect-to-streamline-clinical-trial-operations 2026-08-31T12:32:01+00:00 hourly 0.9 https://trial.medpath.com/news/africa-must-convert-biotechnology-into-wealth-not-just-export-raw-biomass-expert-argues 2026-08-31T12:31:22+00:00 hourly 0.9 https://trial.medpath.com/news/adaptyv-raises-40m-series-a-to-scale-automated-protein-validation-labs-for-ai-driven-drug-discovery 2026-08-31T12:30:56+00:00 hourly 0.9 https://trial.medpath.com/news/andera-partners-olivier-litzka-on-picking-biotech-winners-beyond-the-hype-cycle 2026-08-31T12:30:55+00:00 hourly 0.9 https://trial.medpath.com/news/metag1-launches-controlled-scientific-discussion-platform-for-pharma-and-life-sciences 2026-08-31T12:30:35+00:00 hourly 0.9 https://trial.medpath.com/news/ideaya-announces-successful-fda-type-c-meeting-for-ide849-dll3-top1-adc-in-extensive-stage-small-cell-lung-cancer 2026-08-31T12:30:10+00:00 hourly 0.9 https://trial.medpath.com/news/biotak-score-identifies-broken-heart-syndrome-before-invasive-catheterization 2026-08-31T12:29:45+00:00 hourly 0.9 https://trial.medpath.com/news/nurexone-advances-exosome-based-exopten-toward-clinical-development-for-spinal-cord-and-optic-nerve-regeneration 2026-08-31T12:27:27+00:00 hourly 0.9 https://trial.medpath.com/news/hkbu-inaugural-cxc-session-spotlights-autophagy-as-new-hope-for-brain-diseases 2026-08-31T12:26:08+00:00 hourly 0.9 https://trial.medpath.com/news/adolescent-binge-drinking-causes-lasting-astrocyte-synaptic-disruption-pointing-to-new-treatment-targets 2026-08-31T12:26:04+00:00 hourly 0.9 https://trial.medpath.com/news/ireland-establishes-clinical-trials-advisory-council-to-transform-national-clinical-research-landscape 2026-08-31T12:24:48+00:00 hourly 0.9 https://trial.medpath.com/news/biomarin-secures-20-royalty-on-ascendis-yuviwel-in-global-patent-settlement 2026-08-31T12:23:28+00:00 hourly 0.9 https://trial.medpath.com/news/ena-respiratory-secures-aud-2-98-million-to-advance-inna-051-antiviral-nasal-spray-into-asthma-trial 2026-08-31T12:23:16+00:00 hourly 0.9 https://trial.medpath.com/news/royal-perth-hospital-becomes-first-australian-hospital-licensed-to-manufacture-til-therapies-for-clinical-trials 2026-08-31T12:23:02+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-probiotic-carriers-emerge-as-living-drug-factories-for-tumor-targeted-therapy 2026-08-31T12:22:33+00:00 hourly 0.9 https://trial.medpath.com/news/roche-selects-singapore-as-global-pilot-site-for-precision-medicine-in-cancer 2026-08-31T12:19:46+00:00 hourly 0.9 https://trial.medpath.com/news/leios-therapeutics-licenses-10xb-101-to-china-medical-system-for-focal-fat-reduction 2026-08-31T12:19:44+00:00 hourly 0.9 https://trial.medpath.com/news/bio-visu-s-u-s-sales-surge-past-7-billion-won-as-ecm-skin-booster-business-fuels-global-expansion 2026-08-31T12:19:43+00:00 hourly 0.9 https://trial.medpath.com/news/cna-s-by-your-side-documents-the-daily-realities-of-caregiving-for-rare-diseases-and-neurodegenerative-conditions 2026-08-31T12:19:42+00:00 hourly 0.9 https://trial.medpath.com/news/subsidised-access-to-columvi-glofitamab-now-available-for-relapsed-refractory-dlbcl-patients-in-singapore 2026-08-31T12:19:40+00:00 hourly 0.9 https://trial.medpath.com/news/christus-health-opens-36-million-cancer-center-in-longview-to-address-east-texas-cancer-burden 2026-08-31T12:19:19+00:00 hourly 0.9 https://trial.medpath.com/news/onconic-therapeutics-secures-u-s-patent-for-nesuparib-crystalline-form-and-manufacturing-method 2026-08-31T12:18:56+00:00 hourly 0.9 https://trial.medpath.com/news/aptone-finalizes-fda-phase-3-protocol-for-orphan-drug-gpc-100-a-rapid-acting-stem-cell-mobilizer 2026-08-31T12:18:02+00:00 hourly 0.9 https://trial.medpath.com/news/data4life-and-monash-health-partner-to-advance-clinical-research-with-open-source-rwd-platforms 2026-08-31T12:16:56+00:00 hourly 0.9 https://trial.medpath.com/news/pakistan-to-honor-nurse-who-rescued-sole-survivor-of-hospital-nursery-fire-that-killed-14-newborns 2026-08-31T12:15:39+00:00 hourly 0.9 https://trial.medpath.com/news/biomedit-acquires-folium-science-to-expand-programmable-veterinary-biologics-platform 2026-08-31T12:15:21+00:00 hourly 0.9 https://trial.medpath.com/news/kano-state-launches-special-committee-to-contain-diphtheria-outbreak 2026-08-31T12:14:28+00:00 hourly 0.9 https://trial.medpath.com/news/ai-assisted-digital-pathology-poised-to-transform-hematologic-malignancy-diagnosis 2026-08-31T12:13:03+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-bacteria-recycle-co2-in-situ-to-boost-succinic-acid-production-to-near-industrial-levels 2026-08-31T12:12:25+00:00 hourly 0.9 https://trial.medpath.com/news/kanawha-valley-fellowship-home-advances-phase-ii-expansion-to-extend-sober-living-for-men-in-recovery 2026-08-31T12:10:51+00:00 hourly 0.9 https://trial.medpath.com/news/mckesson-data-breach-shinyhunters-claims-284-million-records-stolen-demands-55-million-ransom 2026-08-31T12:10:16+00:00 hourly 0.9 https://trial.medpath.com/news/h-heft-trial-finds-no-benefit-for-hydralazine-isosorbide-dinitrate-in-heart-failure 2026-08-31T12:06:27+00:00 hourly 0.9 https://trial.medpath.com/news/alnylam-presents-new-data-at-esc-congress-2026-reinforcing-rnai-powered-ttr-silencing-in-attr-cm-and-hypertension 2026-08-31T12:05:22+00:00 hourly 0.9 https://trial.medpath.com/news/fire-at-kyiv-s-sp-hall-business-center-novartis-office-among-those-affected 2026-08-31T12:03:13+00:00 hourly 0.9 https://trial.medpath.com/news/nurse-coordinated-collaborative-care-improves-heart-failure-outcomes-in-time-hf-trial 2026-08-31T11:59:23+00:00 hourly 0.9 https://trial.medpath.com/news/radical-pc-2-specialist-referral-improves-cholesterol-control-but-not-cardiovascular-events-in-prostate-cancer-patients 2026-08-31T11:58:37+00:00 hourly 0.9 https://trial.medpath.com/news/north-carolina-warns-mobile-petting-zoo-visitors-of-rabies-exposure-after-baby-goats-test-positive 2026-08-31T11:55:46+00:00 hourly 0.9 https://trial.medpath.com/news/nanopore-sensor-technology-enables-early-detection-of-parkinson-s-and-als-biomarkers 2026-08-31T11:55:44+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-supreme-court-presses-fssai-on-red-hexagon-front-of-pack-warning-labels-for-hfss-foods 2026-08-31T11:55:43+00:00 hourly 0.9 https://trial.medpath.com/news/dubai-ruler-funds-zolgensma-gene-therapy-for-children-with-spinal-muscular-atrophy 2026-08-31T11:52:45+00:00 hourly 0.9 https://trial.medpath.com/news/immediate-evolocumab-after-heart-attack-improves-ldl-c-goal-attainment-but-not-early-cardiovascular-outcomes 2026-08-31T11:49:48+00:00 hourly 0.9 https://trial.medpath.com/news/arizona-boy-11-diagnosed-with-idiopathic-multicentric-castleman-disease-after-sudden-chest-and-back-pain 2026-08-31T11:47:30+00:00 hourly 0.9 https://trial.medpath.com/news/dutch-drug-institute-issues-red-alert-over-potentially-fatal-trump-shaped-ecstasy-pills-containing-pmma 2026-08-31T11:46:55+00:00 hourly 0.9 https://trial.medpath.com/news/australia-expands-pbs-subsidy-for-keytruda-to-cover-ovarian-bile-duct-and-merkel-cell-cancers 2026-08-31T11:46:18+00:00 hourly 0.9 https://trial.medpath.com/news/codis-completes-acquisition-of-catalent-s-nottingham-facility-creating-europe-s-most-comprehensive-spray-dry-network 2026-08-31T11:46:15+00:00 hourly 0.9 https://trial.medpath.com/news/vijay-pande-launches-vzvc-a-concentrated-ai-biotech-fund-after-building-a16z-s-4-billion-bio-practice 2026-08-31T11:46:11+00:00 hourly 0.9 https://trial.medpath.com/news/blood-cancer-patient-runs-parkrun-to-boost-stem-cell-donor-registration 2026-08-31T11:46:04+00:00 hourly 0.9 https://trial.medpath.com/news/study-finds-women-with-hypoactive-sexual-desire-disorder-still-engage-in-mercy-sex-two-to-three-times-monthly 2026-08-31T11:46:03+00:00 hourly 0.9 https://trial.medpath.com/news/icds-may-benefit-younger-patients-with-mild-to-moderate-heart-dysfunction-cmr-guide-trial-finds 2026-08-31T11:45:08+00:00 hourly 0.9 https://trial.medpath.com/news/who-designates-south-korea-s-ghc-as-world-s-first-collaborating-center-for-medical-product-regulatory-system-training 2026-08-31T11:44:32+00:00 hourly 0.9 https://trial.medpath.com/news/askbio-presents-baseline-characteristics-from-phase-2-genephit-trial-of-umiposgene-parvec-in-heart-failure 2026-08-31T11:44:05+00:00 hourly 0.9 https://trial.medpath.com/news/world-radiotherapy-awareness-day-highlights-growing-global-demand-and-workforce-shortages 2026-08-31T11:43:45+00:00 hourly 0.9 https://trial.medpath.com/news/baldness-drugs-emerge-as-wall-street-s-next-goldmine-as-novel-treatments-near-market 2026-08-31T11:41:40+00:00 hourly 0.9 https://trial.medpath.com/news/total-body-pet-ct-twins-accelerate-research-and-cut-radiation-dose-at-king-s-college-london 2026-08-31T11:41:28+00:00 hourly 0.9 https://trial.medpath.com/news/global-type-1-diabetes-burden-projected-to-rise-29-by-2049-reaching-12-1-million-cases 2026-08-31T11:38:56+00:00 hourly 0.9 https://trial.medpath.com/news/ultrasensitive-salivary-cytokine-profiling-reveals-distinct-immune-signatures-in-dental-caries 2026-08-31T11:38:49+00:00 hourly 0.9 https://trial.medpath.com/news/kelley-wolf-reveals-breakthrough-drug-induced-mania-with-psychosis-diagnosis-one-year-after-mental-health-crisis 2026-08-31T11:38:45+00:00 hourly 0.9 https://trial.medpath.com/news/integrated-experimental-and-computational-exploration-of-18-naphthyridine-hydrazones-published-under-open-access 2026-08-31T11:38:31+00:00 hourly 0.9 https://trial.medpath.com/news/bengaluru-peptide-party-cancelled-after-karnataka-fda-raises-regulatory-and-safety-concerns 2026-08-31T11:38:26+00:00 hourly 0.9 https://trial.medpath.com/news/a-close-trial-antiplatelet-therapy-after-stent-implantation-requires-personalization 2026-08-31T11:38:23+00:00 hourly 0.9 https://trial.medpath.com/news/iowa-launches-i-beacon-program-to-expand-24-7-opioid-treatment-access-statewide 2026-08-31T11:38:20+00:00 hourly 0.9 https://trial.medpath.com/news/poet-ii-trial-cuts-antibiotic-duration-by-two-weeks-in-left-sided-infective-endocarditis-without-compromising-safety 2026-08-31T11:37:12+00:00 hourly 0.9 https://trial.medpath.com/news/atorvastatin-cuts-major-cardiovascular-events-by-30-in-healthy-adults-over-70-staree-trial-finds 2026-08-31T11:33:24+00:00 hourly 0.9 https://trial.medpath.com/news/react-study-early-imaging-detects-silent-atherosclerosis-missed-by-conventional-risk-assessment 2026-08-31T11:33:07+00:00 hourly 0.9 https://trial.medpath.com/news/tranquility-pacibekitug-produces-sustained-reductions-in-inflammatory-markers-in-ckd-patients 2026-08-31T11:33:06+00:00 hourly 0.9 https://trial.medpath.com/news/fda-authorizes-juul-2-e-cigarette-device-and-tobacco-and-menthol-flavored-pods 2026-08-31T11:28:42+00:00 hourly 0.9 https://trial.medpath.com/news/theralase-reports-65-2-complete-response-rate-in-phase-ii-bladder-cancer-study-plans-nda-filing-in-3q2026 2026-08-31T11:27:12+00:00 hourly 0.9 https://trial.medpath.com/news/ai-models-accelerate-rare-disease-diagnosis-at-boston-children-s-and-cheo 2026-08-31T11:26:59+00:00 hourly 0.9 https://trial.medpath.com/news/specialized-lung-vein-cells-actively-drive-pulmonary-fibrosis-revealing-a-new-therapeutic-target 2026-08-31T11:25:58+00:00 hourly 0.9 https://trial.medpath.com/news/dea-revokes-opioid-prescribing-privileges-of-sports-nurse-who-served-elite-athletes 2026-08-31T11:24:51+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-mimrylo-rusfertide-first-in-class-hepcidin-mimetic-for-polycythemia-vera 2026-08-31T11:24:09+00:00 hourly 0.9 https://trial.medpath.com/news/jefferson-county-launches-leave-behind-program-to-distribute-overdose-response-kits-and-connect-at-risk-individuals-to-treatment 2026-08-31T11:23:21+00:00 hourly 0.9 https://trial.medpath.com/news/canada-recruits-64-top-researchers-including-48-from-us-institutions-amid-federal-funding-turmoil 2026-08-31T11:23:13+00:00 hourly 0.9 https://trial.medpath.com/news/germline-variants-define-prognostic-subgroups-in-therapy-related-myeloid-neoplasms 2026-08-31T11:23:11+00:00 hourly 0.9 https://trial.medpath.com/news/nanocarriers-identify-prox1-as-a-new-gene-therapy-target-for-glaucoma 2026-08-31T11:22:13+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-untitled-letter-to-alar-pharmaceuticals-over-promotion-of-unapproved-ketamine-drug-ala-3000 2026-08-31T11:22:04+00:00 hourly 0.9 https://trial.medpath.com/news/electra-therapeutics-launches-phase-1-trial-of-ela822-a-sirpg-specific-antibody-for-chronic-t-cell-mediated-diseases 2026-08-31T11:21:52+00:00 hourly 0.9 https://trial.medpath.com/news/survey-finds-96-of-multiple-myeloma-patients-want-a-role-in-treatment-decisions-yet-most-have-never-heard-of-shared-decision-making 2026-08-31T11:21:49+00:00 hourly 0.9 https://trial.medpath.com/news/multi-omics-maps-compartment-specific-gut-kidney-axis-in-diabetic-kidney-disease-prioritizing-caffeic-acid-and-naringenin-chalcone 2026-08-31T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/bombay-high-court-pulls-up-maharashtra-fda-over-cipla-drug-licence-cancellation 2026-08-28T19:49:32+00:00 hourly 0.9 https://trial.medpath.com/news/xylitol-a-common-sweetener-linked-to-increased-risk-of-heart-attack-and-stroke-in-large-observational-study 2026-08-28T19:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/cytoniche-expands-u-s-fda-regulatory-filings-for-3d-recomtrix-recombinant-collagen-microcarriers 2026-08-28T19:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/bioxcel-therapeutics-files-chapter-11-lines-up-125m-teva-stalking-horse-asset-sale 2026-08-28T18:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/being-first-in-drug-discovery-tracing-the-origins-of-synthetic-medicines 2026-08-28T17:49:42+00:00 hourly 0.9 https://trial.medpath.com/news/ausperbio-completes-120-million-series-c-to-advance-ahb-137-toward-commercialization-in-chronic-hepatitis-b 2026-08-28T17:49:20+00:00 hourly 0.9 https://trial.medpath.com/news/biontech-to-terminate-mid-stage-trial-of-mrna-cancer-vaccine-autogene-cevumeran-in-colorectal-cancer 2026-08-28T17:48:10+00:00 hourly 0.9 https://trial.medpath.com/news/fda-links-30-iv-glutathione-reactions-to-single-medisca-ingredient-lot-used-by-compounding-pharmacies 2026-08-28T16:53:31+00:00 hourly 0.9 https://trial.medpath.com/news/tulane-university-launches-500-million-effort-to-transform-charity-hospital-into-a-biomedical-research-hub 2026-08-28T16:53:19+00:00 hourly 0.9 https://trial.medpath.com/news/biontech-terminates-phase-2-trial-of-autogene-cevumeran-in-resected-colorectal-cancer 2026-08-28T16:51:22+00:00 hourly 0.9 https://trial.medpath.com/news/us-secures-cobalt-60-removed-from-guatemala-to-eliminate-dirty-bomb-risk 2026-08-28T15:49:42+00:00 hourly 0.9 https://trial.medpath.com/news/precision-psychiatry-aims-to-match-schizophrenia-patients-with-tailored-medicines 2026-08-28T15:49:39+00:00 hourly 0.9 https://trial.medpath.com/news/igel-expands-endpoint-options-for-healthcare-and-industrial-environments-with-teguar-hardware 2026-08-28T15:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/formosa-pharmaceuticals-files-cta-for-tsy-110-a-first-in-class-adc-biosimilar-targeting-her2-positive-breast-cancer 2026-08-28T14:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/teva-bids-to-acquire-bioxcel-s-dexmedetomidine-sublingual-film-for-at-home-agitation-treatment 2026-08-28T14:48:16+00:00 hourly 0.9 https://trial.medpath.com/news/jubilant-generics-receives-105-5-crore-gst-show-cause-notice-from-uttarakhand-authorities 2026-08-28T14:48:14+00:00 hourly 0.9 https://trial.medpath.com/news/hiro-and-differentia-biotech-forge-strategic-alliance-to-redefine-clinical-trial-design-through-ai-powered-simulation 2026-08-28T14:48:11+00:00 hourly 0.9 https://trial.medpath.com/news/asieris-launches-cevira-world-s-first-non-invasive-treatment-for-precancerous-cervical-lesions 2026-08-28T13:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/self-assembled-a-helical-peptide-nanopores-enable-ultrasensitive-charge-selective-detection-of-parkinson-s-a-synuclein-variants 2026-08-28T13:48:56+00:00 hourly 0.9 https://trial.medpath.com/news/gilead-opens-182000-square-foot-research-center-advancing-32-billion-u-s-r-d-and-manufacturing-investment 2026-08-28T12:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/transfyr-launches-physical-ai-platform-for-science-with-25m-seed-funding 2026-08-28T12:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/heidelberg-pharma-and-huadong-medicine-expand-partnership-to-co-develop-next-generation-antibody-drug-conjugates 2026-08-28T11:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-marine-bacteria-accelerate-rock-weathering-for-atmospheric-carbon-removal 2026-08-28T09:04:00+00:00 hourly 0.9 https://trial.medpath.com/news/heartflow-ffrct-analysis-cuts-unnecessary-invasive-heart-procedures-by-44-in-government-funded-fusion-trial 2026-08-28T06:48:00+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-trna-restores-full-length-proteins-in-cystic-fibrosis-models-offering-a-common-strategy-for-thousands-of-genetic-diseases 2026-08-28T04:14:00+00:00 hourly 0.9 https://trial.medpath.com/news/rayzebio-announces-173-million-investment-to-expand-radiopharmaceutical-manufacturing-in-indiana 2026-08-28T01:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/knight-therapeutics-submits-supplemental-application-to-anvisa-for-first-line-minjuvi-tafasitamab-in-dlbcl-and-hgbl 2026-08-28T00:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/dolly-parton-offered-to-undergo-experimental-cancer-drug-trials-to-help-future-patients 2026-08-28T00:48:15+00:00 hourly 0.9 https://trial.medpath.com/news/tim-3-identified-as-common-culprit-and-predictive-biomarker-in-severe-bone-infections 2026-08-27T22:54:55+00:00 hourly 0.9 https://trial.medpath.com/news/study-reveals-how-sglt2-inhibitors-improve-failing-heart-function-by-activating-pank1 2026-08-27T22:54:48+00:00 hourly 0.9 https://trial.medpath.com/news/saic-appoints-14-member-science-panel-as-independent-funding-call-opens 2026-08-27T22:54:08+00:00 hourly 0.9 https://trial.medpath.com/news/anthropic-s-model-hardware-standard-lets-ai-agents-autonomously-run-lab-experiments-across-drug-discovery 2026-08-27T21:51:05+00:00 hourly 0.9 https://trial.medpath.com/news/novogene-to-establish-australia-s-first-hospital-co-located-genomics-laboratory-at-cabrini-health 2026-08-27T21:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/karolinska-institutet-temporarily-closes-website-for-technical-maintenance 2026-08-27T21:49:35+00:00 hourly 0.9 https://trial.medpath.com/news/primate-specific-alu-mediated-spast-deletion-reveals-a-druggable-zinc-golgi-pathway-in-dementia-related-neurodegeneration 2026-08-27T21:49:32+00:00 hourly 0.9 https://trial.medpath.com/news/ph-kurien-s-landmark-nexavar-compulsory-licence-india-s-defining-moment-in-affordable-cancer-care 2026-08-27T21:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/rectify-pharmaceuticals-unveils-rty-406-an-oral-dual-abcb4-bsep-modulator-for-primary-sclerosing-cholangitis 2026-08-27T21:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/fred-hutch-launches-15-million-trial-comparing-stem-cell-transplant-vs-non-transplant-therapy-in-older-aml-patients 2026-08-27T20:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/evonik-expands-lipid-based-drug-delivery-capacity-with-new-gmp-facility-in-vancouver 2026-08-27T20:48:48+00:00 hourly 0.9 https://trial.medpath.com/news/oryon-cell-therapies-appoints-kenny-choi-ph-d-as-chief-technical-officer-to-scale-autologous-neuron-replacement-manufacturing 2026-08-27T19:50:03+00:00 hourly 0.9 https://trial.medpath.com/news/scalable-stem-cell-method-advances-off-the-shelf-car-t-therapies 2026-08-27T17:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/new-ceos-at-gsk-novo-nordisk-and-sanofi-chart-divergent-paths-through-pivotal-transitions 2026-08-27T17:49:28+00:00 hourly 0.9 https://trial.medpath.com/news/cansinobio-reports-43-8-revenue-growth-as-overseas-business-and-mrna-pipeline-expand 2026-08-27T17:48:28+00:00 hourly 0.9 https://trial.medpath.com/news/crispr-screen-identifies-crl5socs4-protein-complex-that-tags-tau-for-destruction-in-alzheimer-s-neurons 2026-08-27T16:51:06+00:00 hourly 0.9 https://trial.medpath.com/news/transcutaneous-auricular-vagus-nerve-stimulation-shows-promise-for-chronic-pain-but-evidence-remains-uneven-across-conditions 2026-08-27T16:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-orphan-drug-designation-to-oxcia-s-first-in-class-ogg1-inhibitor-oxc-201-for-ipf 2026-08-27T16:50:16+00:00 hourly 0.9 https://trial.medpath.com/news/brain-biotech-reports-9m-results-continues-to-target-break-even-adjusted-group-ebitda 2026-08-27T15:52:53+00:00 hourly 0.9 https://trial.medpath.com/news/unmc-research-funding-awards-jump-35-to-record-230-million-driven-by-industry-partnerships 2026-08-27T15:51:57+00:00 hourly 0.9 https://trial.medpath.com/news/self-contracting-muscle-grafts-mimic-exercise-benefits-in-aging-mice 2026-08-27T15:51:56+00:00 hourly 0.9 https://trial.medpath.com/news/comparative-oncology-in-canines-advances-personalized-cancer-treatments-for-humans 2026-08-27T15:51:28+00:00 hourly 0.9 https://trial.medpath.com/news/usc-and-ucla-launch-new-ai-degree-programs-to-meet-surging-student-and-employer-demand 2026-08-27T15:51:01+00:00 hourly 0.9 https://trial.medpath.com/news/injectable-hyaluronic-acid-microgels-enable-targeted-minimally-invasive-radiotherapy-for-keloids 2026-08-27T15:51:00+00:00 hourly 0.9 https://trial.medpath.com/news/spain-s-aesan-orders-review-of-menopause-nutrition-guidelines-built-on-male-only-data 2026-08-27T15:50:44+00:00 hourly 0.9 https://trial.medpath.com/news/conavi-medical-secures-fda-510-k-clearance-for-hybrid-ivus-oct-system-advancing-u-s-commercialization 2026-08-27T15:49:12+00:00 hourly 0.9 https://trial.medpath.com/news/mosquito-autodissemination-stations-cut-buruli-ulcer-risk-by-83-in-melbourne-trial 2026-08-27T15:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/cardurion-to-present-phase-2-results-for-pde9-inhibitor-tovinontrine-in-both-major-types-of-heart-failure 2026-08-27T15:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/baseline-nutritional-status-predicts-ketogenic-diet-efficacy-in-pediatric-drug-resistant-epilepsy 2026-08-27T15:48:13+00:00 hourly 0.9 https://trial.medpath.com/news/skeletal-editing-advances-oxygen-to-nitrogen-swap-reprograms-natural-product-activity 2026-08-27T15:39:00+00:00 hourly 0.9 https://trial.medpath.com/news/ai-flags-immune-cold-lobular-breast-cancer-as-potentially-responsive-to-immunotherapy 2026-08-27T14:48:59+00:00 hourly 0.9 https://trial.medpath.com/news/blackstone-s-2-25b-acquisition-of-precision-medicine-group-raises-concerns-over-clinical-trial-and-diagnostic-delays 2026-08-27T14:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/senate-help-chair-cassidy-accuses-mifepristone-makers-of-ignoring-fda-safety-compliance 2026-08-27T14:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/natera-and-angiex-partner-to-assess-response-to-investigational-nuclear-delivered-adc-in-solid-tumors 2026-08-27T14:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/psilera-appoints-neuroscience-veteran-allyson-gage-phd-to-lead-phase-1-trial-of-neuroplastogen-psil-006 2026-08-27T13:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/global-cd70-targeting-therapies-market-report-2026-highlights-expanding-pipeline-and-combination-strategies 2026-08-27T13:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/assessing-the-use-of-non-human-primates-in-translational-research-new-webinar-series-examines-the-evolving-role-of-nhp-models 2026-08-27T12:31:00+00:00 hourly 0.9 https://trial.medpath.com/news/new-documentary-highlights-niacin-sauna-detox-protocol-that-helped-9-11-survivors-recover-from-toxic-exposure 2026-08-27T12:03:00+00:00 hourly 0.9 https://trial.medpath.com/news/apac-cdmos-move-sustainability-from-reporting-to-the-factory-floor-as-greener-manufacturing-becomes-a-business-imperative 2026-08-27T11:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/monod-bio-licenses-ai-designed-protein-technologies-to-signalchem-biotech-for-custom-discovery-assays 2026-08-27T11:48:14+00:00 hourly 0.9 https://trial.medpath.com/news/global-bioresorbable-polymers-market-to-reach-usd-867-2-million-by-2029-growing-at-11-6-cagr 2026-08-27T08:49:23+00:00 hourly 0.9 https://trial.medpath.com/news/abbvie-submits-ema-application-for-skyrizi-subcutaneous-induction-in-crohn-s-disease 2026-08-27T08:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/hvivo-acquires-crs-berlin-to-expand-into-dermatology-and-women-s-health-clinical-trials 2026-08-27T07:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/insulet-reports-second-quarter-2026-revenue-of-802-million-up-23-5 2026-08-27T05:48:16+00:00 hourly 0.9 https://trial.medpath.com/news/daewoong-pharmaceutical-secures-u-s-patent-allowance-for-mrna-anti-aging-delivery-technology 2026-08-27T03:49:43+00:00 hourly 0.9 https://trial.medpath.com/news/american-cancer-society-and-uchicago-medicine-partner-to-build-hope-lodge-chicago-offering-no-cost-lodging-for-traveling-cancer-patients 2026-08-27T01:49:21+00:00 hourly 0.9 https://trial.medpath.com/news/disitamab-vedotin-shows-phase-3-benefit-in-her2-positive-breast-cancer-liver-metastases 2026-08-27T00:49:01+00:00 hourly 0.9 https://trial.medpath.com/news/calcium-scans-add-little-to-prevent-calculator-overall-but-sharpen-statin-decisions-in-borderline-risk 2026-08-26T23:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/new-retina-model-reveals-how-cln3-batten-disease-damages-vision-and-points-to-a-treatment 2026-08-26T23:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/biosidus-brings-new-bioreactor-plant-online-to-expand-agalsidase-beta-supply-for-fabry-disease 2026-08-26T22:55:12+00:00 hourly 0.9 https://trial.medpath.com/news/cu-anschutz-cardiac-tissue-biobanks-advance-heart-disease-research-in-children-and-adults 2026-08-26T22:54:57+00:00 hourly 0.9 https://trial.medpath.com/news/dolly-parton-s-1-million-gift-helped-fund-critical-early-research-behind-moderna-s-covid-19-vaccine 2026-08-26T22:54:49+00:00 hourly 0.9 https://trial.medpath.com/news/ut-md-anderson-president-peter-pisters-announces-retirement-jeffrey-lee-named-interim-president 2026-08-26T22:54:03+00:00 hourly 0.9 https://trial.medpath.com/news/neogenomics-receives-medicare-coverage-for-radar-st-mrd-assay-in-immunotherapy-monitoring 2026-08-26T21:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/new-funding-backs-adelaide-research-to-make-brain-cancer-radiation-therapy-more-effective 2026-08-26T21:50:41+00:00 hourly 0.9 https://trial.medpath.com/news/nfl-and-nflpa-launch-behavioral-health-network-to-expand-confidential-mental-health-access-for-players 2026-08-26T21:49:34+00:00 hourly 0.9 https://trial.medpath.com/news/collagen-supporting-skin-care-ingredients-how-retinoids-and-peptides-help-counter-collagen-loss 2026-08-26T21:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/computer-model-could-streamline-design-of-protein-degrading-cancer-therapies 2026-08-26T20:51:10+00:00 hourly 0.9 https://trial.medpath.com/news/fda-classifies-medline-neonatal-heated-wire-breathing-circuit-recall-as-class-ii 2026-08-26T20:50:54+00:00 hourly 0.9 https://trial.medpath.com/news/ai-based-til-quantification-shows-prognostic-value-in-early-triple-negative-breast-cancer 2026-08-26T20:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/biocon-s-pegfilgrastim-biosimilar-wins-japanese-approval-expanding-biosimilar-footprint 2026-08-26T20:49:49+00:00 hourly 0.9 https://trial.medpath.com/news/university-of-louisville-receives-11-6-million-cobre-grant-to-launch-nutrition-and-metabolic-health-center 2026-08-26T19:49:50+00:00 hourly 0.9 https://trial.medpath.com/news/medtronic-approaches-breakout-as-minimed-spinoff-reaches-record-high 2026-08-26T19:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/bat-encounters-prompt-urgent-rabies-post-exposure-guidance-as-cases-highlight-fatal-risk 2026-08-26T18:50:12+00:00 hourly 0.9 https://trial.medpath.com/news/korea-s-mfds-opens-global-bio-conference-2026-to-accelerate-regulatory-innovation-in-biopharmaceuticals 2026-08-26T18:49:45+00:00 hourly 0.9 https://trial.medpath.com/news/uapb-summer-research-internships-advance-glioblastoma-modeling-and-antibiotic-resistance-alternatives 2026-08-26T18:49:17+00:00 hourly 0.9 https://trial.medpath.com/news/brd4-targeted-therapies-over-20-candidates-in-clinical-trials-as-field-advances-toward-selectivity-and-degradation 2026-08-26T17:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/heidelberg-pharma-and-huadong-medicine-receive-nmpa-approval-for-phase-ib-ii-trial-of-bcma-targeting-adc-hdp-101-in-multiple-myeloma 2026-08-26T17:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-identify-mfd-as-a-new-drug-target-to-combat-airborne-tuberculosis-and-drug-resistance 2026-08-26T17:48:40+00:00 hourly 0.9 https://trial.medpath.com/news/dolly-parton-s-1-million-gift-helped-seed-moderna-s-covid-19-vaccine-research-at-vanderbilt 2026-08-26T17:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/odyssey-therapeutics-to-present-at-september-investor-conferences-as-it-advances-autoimmune-pipeline 2026-08-26T17:01:19+00:00 hourly 0.9 https://trial.medpath.com/news/vesselon-s-triform-platform-delivers-6-fold-more-antibody-drug-to-tumors-while-reducing-off-target-exposure 2026-08-26T17:00:52+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-ind-for-neurocrine-and-nxera-s-oral-m1-agonist-nbi-1117567-in-alzheimer-s-cognition 2026-08-26T17:00:04+00:00 hourly 0.9 https://trial.medpath.com/news/earthjustice-sues-epa-over-fast-tracked-approval-of-toxic-photoacid-generator-forever-chemicals 2026-08-26T17:00:01+00:00 hourly 0.9 https://trial.medpath.com/news/wisconsin-launches-first-statewide-injury-and-violence-prevention-strategic-plan-in-over-a-decade 2026-08-26T16:59:16+00:00 hourly 0.9 https://trial.medpath.com/news/carl-zeiss-foundation-awards-eur-1-5-million-grants-to-kit-scientists-for-cancer-therapy-and-biotechnology-research 2026-08-26T16:59:13+00:00 hourly 0.9 https://trial.medpath.com/news/oig-approves-manufacturer-funded-rare-disease-patient-assistance-program-flags-two-year-ira-review 2026-08-26T16:59:10+00:00 hourly 0.9 https://trial.medpath.com/news/medical-groups-fill-cdc-void-with-independent-2026-27-respiratory-vaccine-guidance 2026-08-26T16:58:34+00:00 hourly 0.9 https://trial.medpath.com/news/umass-lowell-expands-biomedical-engineering-training-pathways-with-new-grants 2026-08-26T16:57:58+00:00 hourly 0.9 https://trial.medpath.com/news/nanoformulation-strategies-to-overcome-multi-drug-resistance-in-cancer-a-call-for-pharmacological-and-translational-rigor 2026-08-26T16:57:39+00:00 hourly 0.9 https://trial.medpath.com/news/agentex-platform-expands-protein-engineering-to-34-amino-acids-without-genome-recoding 2026-08-26T16:56:53+00:00 hourly 0.9 https://trial.medpath.com/news/queen-s-university-belfast-expands-pharmaceutical-analysis-training-to-meet-surging-industry-demand-for-analytical-scientists 2026-08-26T16:55:40+00:00 hourly 0.9 https://trial.medpath.com/news/next-gen-local-drug-delivery-rethinking-oral-cancer-care 2026-08-26T16:55:37+00:00 hourly 0.9 https://trial.medpath.com/news/oncodaily-names-first-20-of-the-100-influential-women-in-oncology-for-2026 2026-08-26T15:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-type-b-pre-ind-meeting-for-rtx-np-mabioncd20-in-immune-thrombocytopenia 2026-08-26T15:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/revir-therapeutics-receives-fda-rare-pediatric-disease-designation-for-rtx-117-in-charcot-marie-tooth-disease 2026-08-26T15:48:34+00:00 hourly 0.9 https://trial.medpath.com/news/for-the-first-time-the-next-dsm-will-integrate-biology-and-biomarkers-into-psychiatric-diagnosis 2026-08-26T15:48:33+00:00 hourly 0.9 https://trial.medpath.com/news/ultra-widefield-oct-a-identifies-quantitative-biomarker-and-four-stage-grading-system-for-retinitis-pigmentosa-severity 2026-08-26T15:48:26+00:00 hourly 0.9 https://trial.medpath.com/news/quantitative-whole-body-mri-shows-promise-as-biomarker-for-disease-progression-in-spinal-and-bulbar-muscular-atrophy 2026-08-26T15:48:06+00:00 hourly 0.9 https://trial.medpath.com/news/wiley-launches-spectral-analysis-api-portfolio-to-bring-gold-standard-reference-data-into-lab-workflows 2026-08-26T14:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/sunshine-biopharma-advances-k1-1-mrna-lipid-nanoparticle-program-toward-dual-therapy-strategy-for-lung-cancer 2026-08-26T13:49:11+00:00 hourly 0.9 https://trial.medpath.com/news/artis-biosolutions-launches-mrna-and-lipid-nanoparticle-manufacturing-at-new-genetic-medicines-center-of-excellence-in-bilbao 2026-08-26T13:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/europe-cancer-vaccines-market-projected-to-reach-2-34-billion-by-2029 2026-08-26T13:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/vivace-therapeutics-advances-vt3989-first-tead-inhibitor-toward-pivotal-phase-3-trial-in-mesothelioma 2026-08-26T12:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/novonesis-expands-u-s-workforce-development-to-build-biomanufacturing-talent-pipeline 2026-08-26T12:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/ultra-processed-foods-linked-to-24-34-higher-prostate-cancer-risk-in-u-s-men 2026-08-26T11:48:03+00:00 hourly 0.9 https://trial.medpath.com/news/sk-biopharm-licenses-biohaven-s-kv7-activator-opakalim-in-795m-deal-targeting-2029-us-launch 2026-08-26T10:48:16+00:00 hourly 0.9 https://trial.medpath.com/news/nationwide-study-finds-no-convincing-biomarkers-for-long-covid-with-lower-inr-the-only-standout-finding 2026-08-26T09:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/shimadzu-invests-in-optqc-to-advance-next-generation-r-d-infrastructure-for-drug-discovery 2026-08-26T08:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/gi-innovation-s-gi-101a-wins-fda-fast-track-designation-for-metastatic-urothelial-carcinoma 2026-08-26T08:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/sex-differences-in-disease-trajectories-after-type-2-diabetes-women-face-earlier-mental-health-burden-men-earlier-cardio-renal-decline 2026-08-26T08:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/no-formaldehyde-detected-in-chinese-cabbage-shipments-tested-at-korean-customs-regulators-say 2026-08-26T08:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/omicsbank-raises-2-25m-to-expand-global-clinical-data-infrastructure-for-drug-development-and-healthcare-ai 2026-08-26T07:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/ai-powered-virtual-patients-help-dental-residents-practice-the-conversations-that-matter 2026-08-26T06:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/applied-pharmacognosy-personalizing-cannabis-dosing-through-real-world-research 2026-08-26T06:48:28+00:00 hourly 0.9 https://trial.medpath.com/news/europe-leads-global-bioconjugation-market-at-1-45-billion-asia-pacific-grows-fastest-at-17-4-cagr 2026-08-26T05:48:37+00:00 hourly 0.9 https://trial.medpath.com/news/cortec-receives-second-fda-breakthrough-device-designation-for-brain-interchange-communication-system 2026-08-26T04:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-7-5-million-to-usc-researchers-to-study-pfas-as-a-driver-of-liver-and-endometrial-cancers 2026-08-26T03:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-de-novo-authorization-to-avulux-precision-light-filtering-lenses-for-migraine-associated-light-sensitivity 2026-08-26T02:48:37+00:00 hourly 0.9 https://trial.medpath.com/news/concordare-trials-secures-funding-to-digitize-clinical-trial-protocols-accelerating-study-activation-by-6-8-weeks 2026-08-26T01:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/haemalogix-doses-first-patient-with-kmcartm-t-cell-therapy-in-phase-1-koala-trial-for-multiple-myeloma 2026-08-26T01:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/wuxi-xdc-h1-2026-revenue-jumps-37-to-rmb-3-7-billion-on-strong-bioconjugate-demand 2026-08-25T23:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/ai-is-reshaping-rna-targeted-drug-discovery-from-small-molecules-to-oligonucleotides 2026-08-25T23:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/mcc-receives-367038-to-expand-robotics-and-automation-training-for-life-sciences-workforce 2026-08-25T20:56:46+00:00 hourly 0.9 https://trial.medpath.com/news/airway-therapeutics-closes-50-million-equity-round-to-advance-zelpultide-alfa-for-bpd-prevention 2026-08-25T20:56:31+00:00 hourly 0.9 https://trial.medpath.com/news/combination-of-jak2-and-parp-inhibitors-shows-early-promise-in-phase-1-trial-for-myelofibrosis 2026-08-25T20:56:12+00:00 hourly 0.9 https://trial.medpath.com/news/apollo-s-pan-rhinovirus-vaccine-apl-10456-triggers-cross-species-t-cell-responses-in-phase-i-trial 2026-08-25T20:56:11+00:00 hourly 0.9 https://trial.medpath.com/news/septerna-appoints-industry-veteran-rajiv-patni-m-d-as-chief-medical-officer 2026-08-25T20:55:25+00:00 hourly 0.9 https://trial.medpath.com/news/berberrubine-alleviates-p-cresyl-sulfate-induced-tubular-injury-via-hnrnpf-nr4a1-er-stress-axis 2026-08-25T19:55:43+00:00 hourly 0.9 https://trial.medpath.com/news/humanity-brings-biological-age-analysis-to-the-u-s-through-quest-diagnostics-questhealth-com 2026-08-25T19:53:01+00:00 hourly 0.9 https://trial.medpath.com/news/iisc-scientists-discover-cow-gut-enzyme-crhab-that-breaks-down-antibiotic-resistant-biofilms 2026-08-25T19:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/pathnet-expands-urologic-pathology-offerings-with-in-house-pten-and-fgfr3-biomarker-testing 2026-08-25T18:50:05+00:00 hourly 0.9 https://trial.medpath.com/news/california-land-use-changes-linked-to-valley-fever-risk-study-finds 2026-08-25T18:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/americans-want-transparency-and-more-say-when-ai-is-used-in-their-healthcare 2026-08-25T17:50:04+00:00 hourly 0.9 https://trial.medpath.com/news/neurologists-see-car-t-potential-in-neuro-immune-diseases-but-safety-and-logistics-will-shape-adoption 2026-08-25T16:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/modex-s-bivalent-ebv-vaccine-targets-two-entry-pathways-to-prevent-200000-cancers-a-year 2026-08-25T15:51:53+00:00 hourly 0.9 https://trial.medpath.com/news/patient-essays-expose-insurer-step-therapy-and-claim-denials-in-cancer-care-as-safe-step-act-push-advances 2026-08-25T15:49:42+00:00 hourly 0.9 https://trial.medpath.com/news/smartphone-enabled-fluorescence-platform-offers-accessible-detection-of-alzheimer-s-amyloid-b-biomarker 2026-08-25T15:49:04+00:00 hourly 0.9 https://trial.medpath.com/news/mahzi-therapeutics-mz-1866-gene-therapy-receives-fda-rare-pediatric-disease-designation-for-pitt-hopkins-syndrome 2026-08-25T15:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/turkey-opens-antitrust-probe-into-teva-over-copaxone-patent-strategy 2026-08-25T15:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/regenxbio-appoints-greg-ciongoli-to-board-of-directors-as-it-prepares-for-commercial-launch 2026-08-25T14:50:45+00:00 hourly 0.9 https://trial.medpath.com/news/welsh-drug-testing-programme-identifies-powerful-new-synthetic-opioids-revealing-an-increasingly-unpredictable-illicit-drug-market 2026-08-25T14:50:09+00:00 hourly 0.9 https://trial.medpath.com/news/pfizer-launches-phase-1-2-trial-of-pf-08154225-across-four-autoimmune-diseases 2026-08-25T14:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/mckesson-to-acquire-precision-medicine-group-for-2-25-billion 2026-08-25T14:49:22+00:00 hourly 0.9 https://trial.medpath.com/news/voluntary-health-industry-deals-on-drug-prices-food-dyes-and-prior-authorization-lack-enforcement-and-fall-short-of-promises 2026-08-25T14:49:16+00:00 hourly 0.9 https://trial.medpath.com/news/cellenkos-receives-fda-fast-track-designation-for-ck0803-in-amyotrophic-lateral-sclerosis 2026-08-25T14:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/natco-pharma-invests-14-million-in-egenesis-deepening-its-bet-on-xenotransplantation 2026-08-25T14:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/allegheny-health-network-and-start-center-announce-strategic-collaboration-to-expand-early-phase-cancer-trial-access-in-western-pennsylvania 2026-08-25T13:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/thermo-fisher-launches-orbitrap-isora-bringing-molecular-level-isotope-ratio-analysis-to-more-labs 2026-08-25T12:30:00+00:00 hourly 0.9 https://trial.medpath.com/news/chugai-files-vamikibart-for-regulatory-approval-in-japan-for-uveitic-macular-edema 2026-08-25T11:49:25+00:00 hourly 0.9 https://trial.medpath.com/news/cambrex-high-point-completes-fda-pmda-and-tga-pre-approval-inspections-advancing-commercial-manufacturing-capabilities 2026-08-25T11:49:24+00:00 hourly 0.9 https://trial.medpath.com/news/central-venous-catheter-use-remains-common-at-hemodialysis-initiation-despite-guideline-recommendations 2026-08-25T11:48:31+00:00 hourly 0.9 https://trial.medpath.com/news/revier-therapeutics-launches-with-eur6m-seed-financing-to-pioneer-class-iia-hdac-inhibitors-for-cardiometabolic-disease 2026-08-25T11:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/cha-biotech-secures-government-backing-to-advance-cell-and-gene-therapy-platforms-toward-clinical-development 2026-08-25T10:48:58+00:00 hourly 0.9 https://trial.medpath.com/news/tulsa-pro-mri-guided-prostate-ablation-expands-to-sutter-health-and-ssm-health-as-incision-free-alternative-to-surgery 2026-08-25T09:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/abio-advances-lanfa-as-a-next-generation-alternative-to-peg-in-drug-delivery 2026-08-25T07:49:03+00:00 hourly 0.9 https://trial.medpath.com/news/fda-updates-leqvio-label-to-recognize-ldl-c-reduction-lowers-cardiovascular-event-risk 2026-08-25T06:49:12+00:00 hourly 0.9 https://trial.medpath.com/news/repurposed-fda-approved-metabolic-drug-starves-cancer-cells-to-death-in-lab-study 2026-08-25T06:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/south-korea-expands-emergency-import-program-to-14-unlicensed-essential-medicines 2026-08-25T05:48:26+00:00 hourly 0.9 https://trial.medpath.com/news/seoul-st-mary-s-hospital-team-selected-for-national-quantum-computing-project-targeting-cardiovascular-precision-medicine 2026-08-25T05:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/biocon-biologics-secures-japanese-approval-for-pegfilgrastim-biosimilar 2026-08-25T05:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/light-driven-method-builds-3d-molecular-scaffolds-to-expand-drug-discovery-options 2026-08-25T05:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/oura-s-ipo-filing-reveals-a-health-data-platform-not-just-a-wearables-company 2026-08-25T05:44:00+00:00 hourly 0.9 https://trial.medpath.com/news/sillajen-s-bal0891-wins-fda-orphan-drug-designation-for-acute-myeloid-leukemia 2026-08-25T04:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/pattern-computer-and-medical-college-of-wisconsin-report-breakthrough-point-of-care-saliva-cancer-screening-results 2026-08-25T00:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/ai-searches-100-million-possibilities-to-democratize-3d-printing-of-nasa-s-grcop-42-alloy 2026-08-25T00:48:50+00:00 hourly 0.9 https://trial.medpath.com/news/astellas-doses-first-patient-in-phase-3-study-of-asp2138-a-subcutaneous-bispecific-t-cell-engager-for-cldn18-2-positive-gastric-cancer 2026-08-25T00:48:40+00:00 hourly 0.9 https://trial.medpath.com/news/celltrion-launches-300-mg-omlyclo-omalizumab-biosimilar-across-key-european-markets 2026-08-24T23:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/fda-finalizes-guidance-on-therapeutic-equivalence-evaluations-for-generic-drugs 2026-08-24T22:55:27+00:00 hourly 0.9 https://trial.medpath.com/news/nad-precursor-supplements-may-undermine-pancreatic-cancer-chemotherapy-study-warns 2026-08-24T20:49:58+00:00 hourly 0.9 https://trial.medpath.com/news/four-gene-fatty-acid-metabolism-signature-distinguishes-diabetic-foot-ulcers-with-high-diagnostic-accuracy 2026-08-24T19:48:59+00:00 hourly 0.9 https://trial.medpath.com/news/image-guided-automation-cuts-organoid-culture-hands-on-time-by-22-hours-weekly 2026-08-24T19:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/government-of-canada-invests-in-workforce-training-to-support-life-sciences-and-biomanufacturing-sector 2026-08-24T19:48:31+00:00 hourly 0.9 https://trial.medpath.com/news/twinstrand-and-university-of-washington-win-245-2-million-final-judgment-against-guardant-health-in-duplex-sequencing-patent-case 2026-08-24T18:49:51+00:00 hourly 0.9 https://trial.medpath.com/news/fda-adds-two-behavioral-health-firms-to-tempo-pilot-including-an-ai-voice-agent-for-talk-therapy 2026-08-24T17:49:36+00:00 hourly 0.9 https://trial.medpath.com/news/peijia-medical-achieves-first-ever-profit-before-tax-on-strong-tavr-growth 2026-08-24T17:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/a-six-year-chase-to-starve-a-deadly-mold-new-3-22m-grant-targets-aspergillus-food-supply 2026-08-24T17:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/precipio-vs-biodesix-diverging-strategies-in-specialty-cancer-diagnostics 2026-08-24T17:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/azenta-appoints-dr-martin-madaus-as-interim-ceo-amid-leadership-transition 2026-08-24T17:48:20+00:00 hourly 0.9 https://trial.medpath.com/news/agc-and-neusignal-therapeutics-collaborate-to-advance-ntx-083-an-oral-alzheimer-s-disease-candidate-toward-u-s-clinical-trials 2026-08-24T16:52:16+00:00 hourly 0.9 https://trial.medpath.com/news/ptc-therapeutics-sephience-sepiapterin-data-reinforce-broad-pku-benefits-including-diet-liberalization-and-sustained-metabolic-control 2026-08-24T16:52:11+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-analysis-accelerates-clinical-development-in-biopharma 2026-08-24T16:50:13+00:00 hourly 0.9 https://trial.medpath.com/news/viva-foundation-to-spotlight-26-late-breaking-clinical-trials-at-the-veins-and-viva-2026 2026-08-24T16:50:13+00:00 hourly 0.9 https://trial.medpath.com/news/cellares-to-lay-off-100-employees-after-losing-large-cell-therapy-manufacturing-partner 2026-08-24T16:49:02+00:00 hourly 0.9 https://trial.medpath.com/news/urinalysis-market-projected-to-reach-7-16-billion-by-2031-driven-by-automation-and-point-of-care-adoption 2026-08-24T16:18:00+00:00 hourly 0.9 https://trial.medpath.com/news/ashland-launches-permexatm-sodium-caprate-to-advance-oral-biologics-delivery 2026-08-24T14:50:16+00:00 hourly 0.9 https://trial.medpath.com/news/japan-approves-brinsupri-brensocatib-as-first-in-class-treatment-for-non-cystic-fibrosis-bronchiectasis 2026-08-24T14:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/liminatus-pharma-engages-synex-as-cro-to-advance-ibc101-cd19xcd22-bivalent-car-t-therapy-in-south-korea 2026-08-24T14:48:33+00:00 hourly 0.9 https://trial.medpath.com/news/amplifica-appoints-hans-hofland-ph-d-as-chief-development-officer-and-william-humphries-to-board-of-directors 2026-08-24T14:48:20+00:00 hourly 0.9 https://trial.medpath.com/news/cognitive-ai-as-a-teammate-cmu-researchers-chart-a-path-for-human-ai-collaboration-in-healthcare 2026-08-24T13:36:00+00:00 hourly 0.9 https://trial.medpath.com/news/citywide-rapid-whole-genome-sequencing-achieves-53-diagnostic-yield-in-critically-ill-children-reshaping-picu-standard-of-care 2026-08-24T12:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/precision-biosciences-doses-first-patient-in-phase-1-2-function-dmd-trial-for-pbgene-dmd 2026-08-24T11:48:37+00:00 hourly 0.9 https://trial.medpath.com/news/edx-medical-raises-ps2-7m-at-44-premium-to-expand-employee-health-screening-service 2026-08-24T09:51:48+00:00 hourly 0.9 https://trial.medpath.com/news/astri-and-saint-francis-university-sign-mou-to-advance-ai-enabled-biomaterials-and-digital-health-innovation 2026-08-24T09:51:16+00:00 hourly 0.9 https://trial.medpath.com/news/synthetic-sugar-molecule-points-to-new-vaccine-antibody-and-diagnostic-routes-for-drug-resistant-hospital-fungus 2026-08-24T08:48:26+00:00 hourly 0.9 https://trial.medpath.com/news/isofol-expands-arfolitixorin-phase-ib-ii-colorectal-cancer-trial-sites-to-accelerate-patient-recruitment 2026-08-24T07:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/counterfeit-and-diverted-cancer-drugs-bengaluru-probe-reaches-90-hospitals-as-delhi-police-bust-rs-9-crore-racket 2026-08-24T06:49:24+00:00 hourly 0.9 https://trial.medpath.com/news/screen-time-in-infancy-and-early-schooling-linked-to-poorer-academic-performance-and-working-memory 2026-08-24T06:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/rfk-jr-s-real-food-show-budget-meal-claims-fail-independent-price-checks 2026-08-24T05:48:20+00:00 hourly 0.9 https://trial.medpath.com/news/illegal-imports-of-wegovy-and-mounjaro-surge-3-5-fold-in-korea-in-first-half-of-2026 2026-08-24T04:48:56+00:00 hourly 0.9 https://trial.medpath.com/news/gc-biopharma-s-hunterase-wins-approval-in-india-and-taiwan-expanding-reach-in-asia-s-rare-disease-market 2026-08-24T04:48:51+00:00 hourly 0.9 https://trial.medpath.com/news/maharashtra-fda-chief-tukaram-mundhe-s-food-safety-crackdown-highlights-health-risks-of-repeated-cooking-oil-use 2026-08-24T03:48:27+00:00 hourly 0.9 https://trial.medpath.com/news/pulnovo-medical-enrolls-first-u-s-patients-in-pulse-lhd-ide-trial-of-padn-for-pulmonary-hypertension-associated-with-left-heart-disease 2026-08-24T03:48:24+00:00 hourly 0.9 https://trial.medpath.com/news/rznomics-joins-lilly-gateway-labs-in-san-diego-to-accelerate-rna-editing-therapeutics 2026-08-24T03:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/small-cap-biotech-and-pharma-weekly-wrap-highlights-sector-momentum 2026-08-24T02:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-accepts-taihe-biotech-s-apixaban-oral-film-beqia-for-substantive-review-pdufa-date-set-for-april-22-2027 2026-08-24T02:58:48+00:00 hourly 0.9 https://trial.medpath.com/news/jw-pharmaceutical-rebrands-frenz-into-a-total-eye-care-megabrand-spanning-drugs-cosmetics-devices-and-food 2026-08-24T02:57:48+00:00 hourly 0.9 https://trial.medpath.com/news/equine-strangles-outbreak-prompts-fair-cancellations-and-precautionary-measures-in-northeast-wisconsin 2026-08-24T01:48:42+00:00 hourly 0.9 https://trial.medpath.com/news/anbogen-and-university-of-tokyo-partner-to-evaluate-abt-301-across-multiple-solid-tumors-via-comparative-oncology 2026-08-24T00:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/9-11-victim-identified-using-first-of-its-kind-genetic-genealogy-technique 2026-08-24T00:48:15+00:00 hourly 0.9 https://trial.medpath.com/news/dogs-and-humans-share-metabolic-biomarkers-of-mortality-dog-aging-project-study-finds 2026-08-24T00:48:14+00:00 hourly 0.9 https://trial.medpath.com/news/novotech-strengthens-presence-in-japan-with-opening-of-tokyo-office 2026-08-23T23:49:54+00:00 hourly 0.9 https://trial.medpath.com/news/eight-year-old-louisiana-girl-dies-after-contracting-rare-brain-eating-amoeba-following-lake-swim 2026-08-23T23:49:39+00:00 hourly 0.9 https://trial.medpath.com/news/nagoya-university-and-fujifilm-develop-next-generation-mrna-delivery-technology-with-circular-rna-and-novel-lipid-nanoparticles 2026-08-23T21:49:31+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-mrna-cancer-immunotherapy-shows-promise-in-high-risk-melanoma-former-fda-chief-says 2026-08-23T19:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/debut-novel-freight-explores-a-10-million-pharmaceutical-drug-heist-through-the-lens-of-the-trucking-industry 2026-08-23T17:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/dissolvable-3d-printed-microneedle-patch-aims-to-improve-localised-skin-cancer-treatment 2026-08-23T17:12:28+00:00 hourly 0.9 https://trial.medpath.com/news/connecticut-officials-warn-of-medetomidine-and-xylazine-contaminating-illicit-fentanyl-supply 2026-08-23T17:10:57+00:00 hourly 0.9 https://trial.medpath.com/news/jubilant-pharmova-receives-us-fda-approval-for-new-isolator-based-fill-and-finish-line-at-spokane-facility 2026-08-23T17:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/zcchc4-boosts-replication-dependent-histone-mrna-translation-via-eif3-interaction 2026-08-23T17:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/declining-childhood-vaccination-rates-drive-resurgence-of-measles-and-pneumonia-risk 2026-08-23T17:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/personalized-mrna-vaccine-paired-with-keytruda-shows-promise-against-melanoma-recurrence 2026-08-23T17:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/weight-regain-after-weight-loss-medication-linked-to-four-fold-rise-in-suicidal-thoughts 2026-08-23T17:06:51+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-ncb-to-launch-24-nationwide-anti-narcotics-drives-targeting-pharmaceutical-drug-diversion 2026-08-23T11:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/doctors-achieve-landmark-recoveries-with-haplo-cord-transplant-and-dual-target-car-t-cell-therapy 2026-08-23T11:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/two-year-trial-finds-mediterranean-style-diet-matches-weight-watchers-for-weight-loss-while-improving-diet-quality 2026-08-23T09:49:12+00:00 hourly 0.9 https://trial.medpath.com/news/more-than-18000-questionable-images-found-in-antibody-catalogues-of-15-companies 2026-08-23T09:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/clinical-trial-treatment-shrinks-rare-thyroid-cancer-tumours-by-60-inspiring-patient-s-charity-ride 2026-08-23T07:48:28+00:00 hourly 0.9 https://trial.medpath.com/news/china-builds-world-s-first-custom-plant-immunity-system-for-epidemic-response 2026-08-23T06:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/officials-warn-wildland-firefighters-about-unproven-glutathione-supplement-for-smoke-exposure 2026-08-23T05:49:26+00:00 hourly 0.9 https://trial.medpath.com/news/india-restricts-cold-medicines-for-children-under-four-over-safety-concerns 2026-08-23T02:48:09+00:00 hourly 0.9 https://trial.medpath.com/news/children-at-the-centre-of-nigeria-s-worsening-drug-crisis 2026-08-23T01:48:35+00:00 hourly 0.9 https://trial.medpath.com/news/orum-therapeutics-announces-u-s-fda-clearance-of-ind-for-orm-1153-a-first-in-class-cd123-gspt1-degrader-antibody-conjugate 2026-08-23T01:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/assam-achieves-world-s-first-ivf-born-lakhimi-calf-a-milestone-in-indigenous-cattle-conservation 2026-08-23T00:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/charles-river-and-medigen-vaccine-biologics-partner-to-advance-next-generation-multivalent-enterovirus-vaccine 2026-08-23T00:48:31+00:00 hourly 0.9 https://trial.medpath.com/news/ankle-co-contraction-explains-why-walking-becomes-harder-with-age-study-finds 2026-08-22T22:56:12+00:00 hourly 0.9 https://trial.medpath.com/news/mobility-tests-offer-valuable-insights-into-healthy-aging-but-they-are-not-a-crystal-ball 2026-08-22T21:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/utoledo-college-of-pharmacy-welcomes-largest-pharm-d-class-in-five-years 2026-08-22T20:48:57+00:00 hourly 0.9 https://trial.medpath.com/news/uk-plans-national-rollout-of-libido-suppressing-drugs-for-sex-offenders-by-december-2028 2026-08-22T18:49:17+00:00 hourly 0.9 https://trial.medpath.com/news/international-overdose-awareness-day-marks-25th-year-as-health-systems-expand-naloxone-access-and-harm-reduction 2026-08-22T18:49:09+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-linked-to-lower-tuberculosis-risk-in-type-2-diabetes 2026-08-22T18:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/eortc-perspective-urges-patient-preferences-as-clinical-trial-endpoints-in-geriatric-oncology 2026-08-22T18:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/medicenna-therapeutics-advances-oncology-immunotherapy-pipeline-ahead-of-september-healthcare-conferences 2026-08-22T17:50:24+00:00 hourly 0.9 https://trial.medpath.com/news/urolithin-a-a-gut-derived-postbiotic-improves-heart-function-in-hfpef-models-by-targeting-pkgia 2026-08-22T16:50:22+00:00 hourly 0.9 https://trial.medpath.com/news/gillette-acquires-south-boston-life-science-site-for-99-29m-pledges-near-1b-investment 2026-08-22T16:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/penn-state-s-stream-platform-condenses-sepsis-diagnosis-from-days-to-hours 2026-08-22T16:49:24+00:00 hourly 0.9 https://trial.medpath.com/news/ai-model-decodes-the-hidden-on-switch-behind-human-gene-activation 2026-08-22T15:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-establishes-new-clinical-manufacturing-facility-in-slovenia-to-accelerate-biological-drug-development 2026-08-22T13:48:16+00:00 hourly 0.9 https://trial.medpath.com/news/assam-s-amch-launches-rare-disease-treatment-as-centre-of-excellence-15-patients-begin-care-on-first-day 2026-08-22T12:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/new-oak-ridge-lab-accelerates-actinium-225-supply-for-next-generation-cancer-therapies 2026-08-22T11:48:14+00:00 hourly 0.9 https://trial.medpath.com/news/nurix-therapeutics-appoints-wes-burwell-as-chief-human-resources-officer-to-support-commercialization-push 2026-08-22T09:53:21+00:00 hourly 0.9 https://trial.medpath.com/news/kacey-musgraves-and-medicine-mama-launch-drought-drops-intimate-wellness-product 2026-08-22T09:50:56+00:00 hourly 0.9 https://trial.medpath.com/news/zydus-lifesciences-receives-usfda-approval-for-ascorbic-acid-injection-with-180-day-cgt-exclusivity 2026-08-22T09:50:52+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-cdsco-expert-committee-recommends-local-trial-waivers-for-generic-lenacapavir-as-hiv-prep 2026-08-22T08:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/blood-based-circular-rnas-emerge-as-a-breakthrough-early-diagnostic-tool-for-alzheimer-s-disease 2026-08-22T07:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/outer-biosciences-trains-ai-on-living-human-skin-to-accelerate-skincare-ingredient-discovery 2026-08-22T07:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/ketamine-s-therapeutic-promise-and-peril-a-cautionary-tale-of-unsupervised-use 2026-08-22T07:07:06+00:00 hourly 0.9 https://trial.medpath.com/news/massachusetts-woman-sentenced-to-two-years-for-selling-body-parts-stolen-from-harvard-medical-school-morgue 2026-08-22T00:48:13+00:00 hourly 0.9 https://trial.medpath.com/news/reinforcement-learning-framework-fine-tunes-flow-matching-models-for-controllable-3d-drug-design 2026-08-22T00:48:06+00:00 hourly 0.9 https://trial.medpath.com/news/identification-and-characterization-of-mitochondrial-e3-ubiquitin-protein-ligase-1-mul1-in-disease-regulation 2026-08-21T23:48:06+00:00 hourly 0.9 https://trial.medpath.com/news/child-diagnosed-with-tuberculosis-at-launceston-childcare-centre-prompts-precautionary-testing 2026-08-21T22:55:08+00:00 hourly 0.9 https://trial.medpath.com/news/eight-month-old-becomes-first-in-world-to-receive-precision-medicine-for-kcnt1-related-catastrophic-epilepsy 2026-08-21T22:54:11+00:00 hourly 0.9 https://trial.medpath.com/news/capillaries-not-arteries-drive-formation-of-the-heart-s-natural-bypass-vessels 2026-08-21T21:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-merck-mrna-cancer-therapy-hits-primary-endpoint-sending-biotech-stocks-to-post-pandemic-highs 2026-08-21T21:48:37+00:00 hourly 0.9 https://trial.medpath.com/news/hhs-launches-first-ever-national-autism-missing-and-endangered-person-alert-initiative 2026-08-21T21:48:29+00:00 hourly 0.9 https://trial.medpath.com/news/u-s-employer-health-care-costs-projected-to-rise-9-5-in-2027-marking-fourth-consecutive-year-of-near-double-digit-growth 2026-08-21T21:48:10+00:00 hourly 0.9 https://trial.medpath.com/news/dsm-firmenich-initiates-patent-infringement-litigation-in-china-over-biotech-sclareol-production 2026-08-21T19:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/blood-collection-devices-market-to-reach-15-88-billion-by-2034-as-chronic-disease-testing-surges 2026-08-21T19:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/australian-researchers-uncover-molecular-switch-driving-triple-negative-breast-cancer-metastasis-pointing-to-cdk4-6-inhibitor-repurposing 2026-08-21T17:48:59+00:00 hourly 0.9 https://trial.medpath.com/news/chemotherapy-free-four-drug-regimen-yields-97-clinical-benefit-in-her2-positive-hr-positive-metastatic-breast-cancer 2026-08-21T16:50:54+00:00 hourly 0.9 https://trial.medpath.com/news/younger-lung-cancer-patients-show-more-targetable-gene-alterations-supporting-broader-genomic-profiling 2026-08-21T16:50:30+00:00 hourly 0.9 https://trial.medpath.com/news/when-ai-designs-a-drug-who-gets-the-credit-the-legal-wrinkle-in-ai-driven-drug-discovery 2026-08-21T15:51:26+00:00 hourly 0.9 https://trial.medpath.com/news/neuroone-wins-iso-13485-certification-opening-international-markets-for-onerf-ablation-platforms 2026-08-21T15:51:16+00:00 hourly 0.9 https://trial.medpath.com/news/carrie-ann-inaba-partners-with-novartis-to-raise-sjogren-s-disease-awareness 2026-08-21T15:48:50+00:00 hourly 0.9 https://trial.medpath.com/news/werewolf-and-ambros-therapeutics-announce-merger-to-advance-neridronate-as-potential-first-fda-approved-treatment-for-crps-1 2026-08-21T13:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/luye-pharma-advances-therapeutic-mrna-vaccine-ly01620-into-phase-ii-for-hpv16-positive-cervical-lesions 2026-08-21T13:48:54+00:00 hourly 0.9 https://trial.medpath.com/news/digital-empower-program-reduces-anxiety-and-depression-in-adults-with-chronic-conditions-with-self-directed-delivery-matching-human-supported-outcomes 2026-08-21T13:48:53+00:00 hourly 0.9 https://trial.medpath.com/news/men-with-heart-disease-face-higher-risk-of-developing-and-dying-from-cancer-25-year-study-finds 2026-08-21T13:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/ai-predicts-vaccine-response-before-vaccination-using-pre-existing-antibody-patterns 2026-08-21T13:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/blood-protein-biomarkers-b2m-and-cystatin-c-predict-future-disability-in-very-old-adults 2026-08-21T12:48:40+00:00 hourly 0.9 https://trial.medpath.com/news/curegene-doses-first-participant-in-phase-i-trial-of-oral-liver-targeting-thr-b-agonist-cg-0416 2026-08-21T12:48:39+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-personalized-mrna-cancer-therapy-sector-accelerates-as-lk101-advances-toward-clinical-validation 2026-08-21T11:48:23+00:00 hourly 0.9 https://trial.medpath.com/news/orphan-gpcr-gpr52-governs-collective-invasion-and-multicellular-organization-in-breast-cancer 2026-08-21T10:48:45+00:00 hourly 0.9 https://trial.medpath.com/news/nigeria-approves-revised-national-biotechnology-policy-2026-to-advance-research-and-commercialisation 2026-08-21T10:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/propionyl-coa-drives-cholesterol-production-and-hormone-therapy-resistance-in-prostate-cancer-weill-cornell-study-finds 2026-08-21T09:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/antiseizure-medication-choice-alters-stroke-and-bleeding-risk-in-epilepsy-patients-on-doacs 2026-08-21T09:48:13+00:00 hourly 0.9 https://trial.medpath.com/news/implantica-receives-fda-approval-for-refluxstop-opening-the-u-s-market-for-gerd-treatment 2026-08-21T07:48:36+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-find-possible-new-route-to-more-powerful-mrna-drugs 2026-08-21T05:49:08+00:00 hourly 0.9 https://trial.medpath.com/news/python-named-jodie-foster-becomes-first-snake-to-receive-pioneering-electrochemotherapy-cancer-treatment 2026-08-21T04:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/oklahoma-heart-institute-brings-national-cardiovascular-clinical-trials-to-tulsa 2026-08-21T04:49:15+00:00 hourly 0.9 https://trial.medpath.com/news/sunshine-guojian-posts-95-profit-surge-as-two-autoimmune-antibodies-win-nmpa-approval 2026-08-21T02:49:07+00:00 hourly 0.9 https://trial.medpath.com/news/china-approves-two-homegrown-long-acting-rsv-antibodies-for-infants-challenging-beyfortus 2026-08-21T02:48:52+00:00 hourly 0.9 https://trial.medpath.com/news/opko-health-secures-125-million-non-dilutive-financing-against-mazdutide-royalties 2026-08-21T01:49:05+00:00 hourly 0.9 https://trial.medpath.com/news/multi-organ-chip-uncovers-key-mechanisms-behind-cancer-metastasis 2026-08-21T01:48:47+00:00 hourly 0.9 https://trial.medpath.com/news/dll3-targeted-therapies-market-poised-to-exceed-2-billion-by-2030-as-combination-strategies-accelerate 2026-08-21T01:48:22+00:00 hourly 0.9 https://trial.medpath.com/news/fronteo-and-science-tokyo-launch-ai-drug-discovery-ecosystem-collaborative-research-cluster 2026-08-21T01:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/heartbeat-powered-battery-free-pacemaker-could-last-a-lifetime 2026-08-20T22:54:10+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-2-million-to-virginia-tech-virologist-to-decode-how-infected-cells-decide-to-live-or-die 2026-08-20T22:53:58+00:00 hourly 0.9 https://trial.medpath.com/news/superbrewed-food-launches-thryvia-a-shelf-stable-protein-derived-postbiotic-for-gut-and-immune-health 2026-08-20T22:53:43+00:00 hourly 0.9 https://trial.medpath.com/news/time-restricted-eating-lowers-blood-sugar-in-adults-with-type-1-diabetes-without-raising-safety-risks 2026-08-20T22:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/ac-immune-s-brain-penetrant-nlrp3-inhibitor-aci-19764-shows-safety-and-csf-exposure-in-first-in-human-study 2026-08-20T21:51:09+00:00 hourly 0.9 https://trial.medpath.com/news/apec-economies-advance-genome-editing-and-biotechnology-to-strengthen-food-security 2026-08-20T21:51:08+00:00 hourly 0.9 https://trial.medpath.com/news/def-leppard-s-vivian-campbell-reveals-hodgkin-lymphoma-relapse-after-donor-transplant 2026-08-20T21:51:03+00:00 hourly 0.9 https://trial.medpath.com/news/pulse-pharmaceuticals-secures-world-first-approval-for-nanocarrier-entrapped-vitamin-d3-oral-dispersion 2026-08-20T21:50:56+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-and-institut-pasteur-sign-strategic-research-collaboration-to-advance-mrna-vaccines-for-infectious-diseases 2026-08-20T21:50:04+00:00 hourly 0.9 https://trial.medpath.com/news/ukzn-s-tricia-naicker-honored-for-pioneering-antimicrobial-resistance-drug-discovery 2026-08-20T21:49:41+00:00 hourly 0.9 https://trial.medpath.com/news/adaptin-bio-opens-enrollment-in-phase-1-trial-of-aptn-101-for-egfrviii-positive-glioblastoma 2026-08-20T21:48:46+00:00 hourly 0.9 https://trial.medpath.com/news/varmx-enrolls-first-participant-in-global-phase-3-equilibrix-s-trial-of-vmx-c001-for-urgent-surgery 2026-08-20T19:51:07+00:00 hourly 0.9 https://trial.medpath.com/news/splash-beverage-group-rebrands-as-endovia-health-sciences-pivoting-to-cannabinoid-pharmaceuticals 2026-08-20T19:49:40+00:00 hourly 0.9 https://trial.medpath.com/news/ovarian-aging-emerges-as-a-central-driver-of-women-s-health-span 2026-08-20T19:48:55+00:00 hourly 0.9 https://trial.medpath.com/news/wisconsin-seeks-public-input-on-allocating-874-million-in-opioid-settlement-funds 2026-08-20T18:48:43+00:00 hourly 0.9 https://trial.medpath.com/news/radioligand-therapy-market-projected-to-reach-15-85-billion-by-2035-as-alpha-emitter-pipeline-matures 2026-08-20T18:30:00+00:00 hourly 0.9 https://trial.medpath.com/news/right-to-try-vs-expanded-access-examining-the-regulatory-claims-behind-a-high-profile-cancer-survival-story 2026-08-20T17:50:45+00:00 hourly 0.9 https://trial.medpath.com/news/metabolic-syndrome-emerges-rapidly-in-first-year-of-adt-arpi-therapy-for-prostate-cancer 2026-08-20T17:50:42+00:00 hourly 0.9 https://trial.medpath.com/news/ictriplex-triplet-strategy-achieves-47-9-complete-remission-in-advanced-refractory-malignancies 2026-08-20T17:50:07+00:00 hourly 0.9 https://trial.medpath.com/news/ild-day-2026-spotlights-precision-medicine-s-potential-to-transform-interstitial-lung-disease-care 2026-08-20T17:50:04+00:00 hourly 0.9 https://trial.medpath.com/news/astromech-raises-20m-to-build-ai-models-that-predict-evolutionary-change-reaching-3-8b-valuation 2026-08-20T17:45:00+00:00 hourly 0.9 https://trial.medpath.com/news/nih-reverses-trump-era-ban-on-south-african-research-funding-reopening-hiv-and-tb-collaborations 2026-08-20T16:53:06+00:00 hourly 0.9 https://trial.medpath.com/news/michigan-reports-first-human-case-of-eastern-equine-encephalitis-since-2021 2026-08-20T16:50:44+00:00 hourly 0.9 https://trial.medpath.com/news/arpa-h-awards-31-1m-to-siemens-healthineers-for-autonomous-endovascular-stroke-robotics 2026-08-20T16:49:49+00:00 hourly 0.9 https://trial.medpath.com/news/epic-signals-a-shift-toward-patient-directed-ai-as-ehr-giant-weighs-direct-to-consumer-power 2026-08-20T16:49:44+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-rha-redensity-eye-for-undereye-hollowing-in-adults-22-and-older 2026-08-20T15:50:34+00:00 hourly 0.9 https://trial.medpath.com/news/geroscience-pioneer-nir-barzilai-pursues-repurposed-drugs-and-longevity-genes-to-extend-health-span 2026-08-20T15:50:24+00:00 hourly 0.9 https://trial.medpath.com/news/geovax-ceo-david-dodd-to-present-at-2026-georgia-life-sciences-summit-as-company-advances-mva-vaccine-and-oncology-pipeline 2026-08-20T15:49:43+00:00 hourly 0.9 https://trial.medpath.com/news/b-braun-issues-voluntary-nationwide-recall-of-0-9-sodium-chloride-injection-due-to-zinc-oxide-particulate-contamination 2026-08-20T15:49:27+00:00 hourly 0.9 https://trial.medpath.com/news/everglade-adds-former-arpa-h-scientific-advisor-kate-teffer-to-expand-federal-health-research-capabilities 2026-08-20T15:48:32+00:00 hourly 0.9 https://trial.medpath.com/news/no-risk-free-nicotine-use-review-maps-biological-hierarchy-of-cardiovascular-harm-across-all-delivery-methods 2026-08-20T15:48:25+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-draft-guidance-on-potency-assessment-for-active-immunotherapy-products 2026-08-20T14:48:45+00:00 hourly 0.9 https://trial.medpath.com/news/andrea-maier-s-precision-medicine-approach-aims-to-give-longevity-science-a-solid-evidence-base 2026-08-20T14:48:17+00:00 hourly 0.9 https://trial.medpath.com/news/creative-biolabs-expands-complement-assays-and-adds-immunology-microfluidic-capabilities-for-biotherapeutics-research 2026-08-20T13:51:14+00:00 hourly 0.9 https://trial.medpath.com/news/children-s-hospital-launches-canada-s-first-paediatric-olink-lab-advancing-precision-medicine-for-children 2026-08-20T13:50:54+00:00 hourly 0.9 https://trial.medpath.com/news/federal-circuit-upholds-ptab-obviousness-rulings-against-10x-genomics-single-cell-sequencing-patents 2026-08-20T13:50:51+00:00 hourly 0.9 https://trial.medpath.com/news/precision-for-medicine-names-amanda-owens-gm-of-biospecimen-solutions-to-expand-access-to-characterized-samples 2026-08-20T13:49:35+00:00 hourly 0.9 https://trial.medpath.com/news/cure-alzheimer-s-fund-appoints-stephanie-wasco-as-executive-vice-president-of-marketing-and-communications 2026-08-20T13:48:38+00:00 hourly 0.9 https://trial.medpath.com/news/special-journal-issue-maps-global-cancer-epidemiology-and-charts-the-path-to-precision-prevention 2026-08-20T13:48:08+00:00 hourly 0.9 https://trial.medpath.com/news/review-maps-path-from-foundation-models-to-accountable-clinical-ai-in-medical-imaging 2026-08-20T13:44:00+00:00 hourly 0.9 https://trial.medpath.com/news/eyconis-initiates-first-in-human-trial-of-long-acting-anti-vegf-therapy-eyc-0305-in-treatment-naive-wet-amd 2026-08-20T12:49:30+00:00 hourly 0.9 https://trial.medpath.com/news/ema-recommends-approval-for-biosimilar-pegfilgrastim-cavoley 2026-08-20T12:49:11+00:00 hourly 0.9 https://trial.medpath.com/news/glenmark-receives-us-fda-approval-for-fluticasone-propionate-nasal-spray 2026-08-20T12:49:06+00:00 hourly 0.9 https://trial.medpath.com/news/maxcyte-launches-change-seq-be-and-one-seq-be-to-strengthen-off-target-assessment-for-base-editing-therapies 2026-08-20T11:53:42+00:00 hourly 0.9 https://trial.medpath.com/news/lucid-group-names-eric-muller-as-ceo-to-lead-next-phase-of-growth 2026-08-20T11:53:20+00:00 hourly 0.9 https://trial.medpath.com/news/spago-nanomedical-s-tumorad-01-hits-mtd-endpoint-pivots-to-head-and-neck-cancer 2026-08-20T11:51:53+00:00 hourly 0.9 https://trial.medpath.com/news/medivir-reports-q2-2026-fostrox-phase-2-flex-hcc-underway-miv-711-expanded-into-perthes-disease 2026-08-20T11:51:41+00:00 hourly 0.9 https://trial.medpath.com/news/supercentenarians-harbor-abundant-cancer-killing-cd4-cytotoxic-t-cells-without-exhaustion 2026-08-20T11:51:02+00:00 hourly 0.9 https://trial.medpath.com/news/smart-cancer-drug-rk-251-activates-only-in-cancer-cells-offering-targeted-alternative-to-chemotherapy 2026-08-20T10:04:23+00:00 hourly 0.9 https://trial.medpath.com/news/pixelgen-technologies-secures-eur13-26-million-series-b-to-advance-spatial-mapping-of-cell-surface-proteins 2026-08-20T10:04:09+00:00 hourly 0.9 https://trial.medpath.com/news/gubra-advances-obesity-pipeline-as-abbvie-and-boehringer-ingelheim-programs-reach-phase-2 2026-08-20T10:03:24+00:00 hourly 0.9 https://trial.medpath.com/news/alpk3-gene-therapy-reverses-severe-childhood-cardiomyopathy-in-mouse-and-human-models 2026-08-20T10:03:06+00:00 hourly 0.9 https://trial.medpath.com/news/cocrystal-pharma-completes-dosing-in-phase-1b-human-challenge-trial-of-oral-norovirus-antiviral-cdi-988 2026-08-20T10:02:20+00:00 hourly 0.9 https://trial.medpath.com/news/fda-authorizes-first-of-its-kind-robotic-blood-draw-device-aletta 2026-08-20T10:01:02+00:00 hourly 0.9 https://trial.medpath.com/news/rfk-jr-highlights-unmc-s-biocontainment-preparedness-and-nutrition-education-initiatives-during-nebraska-visit 2026-08-20T09:34:00+00:00 hourly 0.9 https://trial.medpath.com/news/hlb-reports-sharp-revenue-decline-and-widening-losses-in-h1-2025-amid-oncology-pipeline-push 2026-08-20T05:48:11+00:00 hourly 0.9 https://trial.medpath.com/news/combined-calcium-ionophore-and-pentoxifylline-improve-embryo-quality-in-dual-gamete-deficiency-mouse-model 2026-08-20T05:48:09+00:00 hourly 0.9 https://trial.medpath.com/news/colorectal-tumors-may-damage-peripheral-nerves-before-chemotherapy-begins 2026-08-20T03:50:53+00:00 hourly 0.9 https://trial.medpath.com/news/surprise-discovery-a-known-tb-gene-springs-to-action-under-stress-revealing-a-new-drug-target 2026-08-20T01:30:37+00:00 hourly 0.9 https://trial.medpath.com/news/cuh-chief-executive-warns-hospital-is-unsafe-for-patients-amid-over-1000-staff-shortfall 2026-08-20T01:27:40+00:00 hourly 0.9 https://trial.medpath.com/news/host-defense-launches-immune-whole-body-support-a-functional-mushroom-supplement-for-dogs-and-cats 2026-08-20T01:26:51+00:00 hourly 0.9 https://trial.medpath.com/news/neoimmunetech-licenses-il-7-therapy-nt-i7-to-tolerance-bio-in-deal-worth-up-to-260-million 2026-08-20T01:24:26+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-accelerated-approval-to-ultragenyx-s-genglycos-first-gene-therapy-for-glycogen-storage-disease-type-ia 2026-08-20T01:24:24+00:00 hourly 0.9 https://trial.medpath.com/news/digital-integrative-medicine-program-improves-overall-survival-in-patients-undergoing-systemic-cancer-treatment 2026-08-20T01:24:10+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-engineer-brain-organoids-with-distinct-cortical-regional-identity-to-study-fragile-x-syndrome 2026-08-20T01:22:53+00:00 hourly 0.9 https://trial.medpath.com/news/apoe-stratified-gwas-uncovers-new-alzheimer-s-risk-loci-and-supports-a-priori-apoe-stratification-in-ad-trials 2026-08-20T01:22:53+00:00 hourly 0.9 https://trial.medpath.com/news/colorado-sues-geo-group-to-force-compliance-with-tuberculosis-investigation-at-aurora-ice-detention-center 2026-08-19T22:16:00+00:00 hourly 0.9 https://trial.medpath.com/news/trump-picks-white-house-aide-dr-heidi-overton-to-lead-fda 2026-08-19T20:55:02+00:00 hourly 0.9 https://trial.medpath.com/news/aurinia-settles-patent-litigation-with-teva-securing-u-s-exclusivity-for-lupkynis-until-2036 2026-08-19T20:54:57+00:00 hourly 0.9 https://trial.medpath.com/news/auragxp-secures-initial-seed-funding-and-expands-executive-leadership-to-advance-ai-native-life-sciences-platform 2026-08-19T19:49:34+00:00 hourly 0.9 https://trial.medpath.com/news/delayed-sting-activation-strategy-enhances-antitumor-immunity-of-mrna-cancer-vaccines 2026-08-19T18:49:52+00:00 hourly 0.9 https://trial.medpath.com/news/bacterial-antibiotic-gladiolin-disarms-candida-albicans-by-forcing-it-back-to-a-harmless-state 2026-08-19T18:49:52+00:00 hourly 0.9 https://trial.medpath.com/news/aaadv-2026-workshop-to-confront-the-hardest-questions-in-global-cancer-drug-development 2026-08-19T18:49:44+00:00 hourly 0.9 https://trial.medpath.com/news/mapping-b7-h3-across-the-tumour-microenvironment-reveals-vascular-and-myeloid-compartments-as-key-targets 2026-08-19T18:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/coregen-s-crispr-edited-treg-therapy-crg-150-advances-to-first-in-human-trial-in-breast-and-prostate-cancers 2026-08-19T18:48:13+00:00 hourly 0.9 https://trial.medpath.com/news/revelation-biosciences-selects-avance-clinical-as-cro-for-phase-2-3-titan-study-of-gemini-in-acute-kidney-injury 2026-08-19T18:48:07+00:00 hourly 0.9 https://trial.medpath.com/news/trump-nominates-heidi-overton-to-lead-the-fda 2026-08-19T18:48:01+00:00 hourly 0.9 https://trial.medpath.com/news/arcato-s-arc-001-gel-meets-safety-endpoint-in-phase-1-trial-showing-durable-analgesia-after-third-molar-surgery 2026-08-19T18:14:36+00:00 hourly 0.9 https://trial.medpath.com/news/new-post-exposure-covid-19-prevention-medicine-available-as-transmission-rises-nationwide 2026-08-19T18:14:22+00:00 hourly 0.9 https://trial.medpath.com/news/jocasta-neuroscience-secures-direct-ucsf-license-for-a-klotho-clearing-path-to-2027-phase-i-trial 2026-08-19T18:14:13+00:00 hourly 0.9 https://trial.medpath.com/news/bracco-launches-bubblegen-cd3-t-cell-selection-kit-for-bead-free-cell-therapy-manufacturing 2026-08-19T18:13:36+00:00 hourly 0.9 https://trial.medpath.com/news/kynexis-extends-series-a-to-eur97-million-to-advance-first-in-class-kat-ii-inhibitor-for-cognitive-impairment-in-schizophrenia 2026-08-19T18:13:24+00:00 hourly 0.9 https://trial.medpath.com/news/zeiss-clinic-360-gains-fda-510-k-clearance-for-cloud-based-ophthalmic-workflow-solution 2026-08-19T18:13:22+00:00 hourly 0.9 https://trial.medpath.com/news/ryvu-therapeutics-launches-keelira-a-specialized-cro-for-european-phase-i-ii-oncology-development 2026-08-19T18:13:19+00:00 hourly 0.9 https://trial.medpath.com/news/genentech-announces-750-million-device-fill-finish-manufacturing-expansion-in-hillsboro-oregon 2026-08-19T18:13:11+00:00 hourly 0.9 https://trial.medpath.com/news/femasys-announces-fda-approval-of-modular-pma-pathway-for-fembloc-non-surgical-permanent-birth-control 2026-08-19T18:12:44+00:00 hourly 0.9 https://trial.medpath.com/news/purdue-s-stei-method-eliminates-sample-preparation-for-spatial-multiomics-analysis 2026-08-19T18:12:42+00:00 hourly 0.9 https://trial.medpath.com/news/the-exocrine-pancreas-emerges-as-a-critical-player-in-diabetes-pathophysiology-and-care 2026-08-19T18:11:50+00:00 hourly 0.9 https://trial.medpath.com/news/gsk-s-mrna-patent-showdown-against-moderna-biontech-and-pfizer-opens-at-the-hague-upc 2026-08-19T18:11:15+00:00 hourly 0.9 https://trial.medpath.com/news/international-task-force-outlines-roadmap-for-precision-stroke-recovery-using-molecular-biomarkers 2026-08-19T18:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/indigo-light-may-prevent-and-treat-myopia-by-restoring-a-missing-wavelength-in-indoor-lighting 2026-08-19T18:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/foresite-labs-appoints-dr-jorge-reis-filho-to-lead-ai-driven-biomedical-discovery-strategy 2026-08-19T18:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/uvm-launches-tuition-free-biotechnology-technician-certificate-to-build-regional-life-sciences-workforce 2026-08-19T18:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/sino-biopharmaceutical-unveils-global-brand-sbp-group-to-accelerate-international-expansion 2026-08-19T18:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/network-bio-launches-with-50m-to-build-first-cell-free-rna-foundation-model-with-nvidia 2026-08-19T18:06:23+00:00 hourly 0.9 https://trial.medpath.com/news/mosaic-self-assembling-dna-fragments-could-overcome-the-bottleneck-in-writing-long-complex-sequences 2026-08-19T13:51:01+00:00 hourly 0.9 https://trial.medpath.com/news/uk-mhra-approves-deciphera-s-vimseltinib-romvimza-for-tenosynovial-giant-cell-tumour 2026-08-19T13:50:34+00:00 hourly 0.9 https://trial.medpath.com/news/henlius-reports-2026-interim-results-serplulimab-becomes-first-anti-pd-1-mab-approved-for-perioperative-gastric-cancer 2026-08-19T12:52:50+00:00 hourly 0.9 https://trial.medpath.com/news/crescendo-health-appoints-david-strutton-phd-as-chief-scientific-officer 2026-08-19T12:52:26+00:00 hourly 0.9 https://trial.medpath.com/news/weight-loss-medications-not-linked-to-higher-respiratory-adverse-event-risk-meta-analysis-finds 2026-08-19T12:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/patients-and-researchers-challenge-fda-approved-cancer-drug-dosages-citing-billions-in-potential-savings-and-avoidable-toxicity 2026-08-19T10:52:41+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-risk-score-identifies-hidden-type-1-diabetes-in-nearly-one-in-five-mody-referrals 2026-08-19T10:52:39+00:00 hourly 0.9 https://trial.medpath.com/news/norroy-bioscience-s-68ga-nym096-receives-fda-breakthrough-therapy-and-fast-track-designations-for-ccrcc-pet-imaging 2026-08-19T09:50:13+00:00 hourly 0.9 https://trial.medpath.com/news/lundbeck-reports-16-cer-revenue-growth-in-h1-2026-driven-by-vyepti-and-advancing-pipeline 2026-08-19T08:02:56+00:00 hourly 0.9 https://trial.medpath.com/news/ultragenyx-secures-first-gene-therapy-approval-and-priority-review-voucher-lifting-rare-stock-6-after-hours 2026-08-19T08:02:50+00:00 hourly 0.9 https://trial.medpath.com/news/medication-mix-up-at-ascension-saint-thomas-hospital-midtown-leaves-72-year-old-woman-paralyzed-four-patients-harmed 2026-08-19T05:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/laser-interstitial-thermal-therapy-extends-survival-in-glioblastoma-when-tumor-ablation-exceeds-91-and-treatment-occurs-early 2026-08-19T04:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/harvard-medical-school-agrees-to-53-million-settlement-over-morgue-body-parts-scandal 2026-08-19T02:48:41+00:00 hourly 0.9 https://trial.medpath.com/news/wellspring-consumer-healthcare-launches-seven-hypochlorous-acid-products-across-its-personal-care-portfolio 2026-08-19T02:48:08+00:00 hourly 0.9 https://trial.medpath.com/news/10x-health-advances-precision-nutrition-platform-expanding-internationally-through-m42-partnership-in-abu-dhabi 2026-08-19T01:50:53+00:00 hourly 0.9 https://trial.medpath.com/news/uab-heersink-school-of-medicine-awards-inaugural-team-science-grants-to-tackle-complex-health-challenges 2026-08-19T01:48:20+00:00 hourly 0.9 https://trial.medpath.com/news/alzamend-neuro-s-al001-lithium-imaging-data-accepted-for-oral-presentation-at-ismrm-x-nuclei-workshop 2026-08-19T01:48:19+00:00 hourly 0.9 https://trial.medpath.com/news/how-decades-of-publicly-funded-biomedical-research-translate-into-patient-care 2026-08-19T00:48:21+00:00 hourly 0.9 https://trial.medpath.com/news/curavit-acquires-lindus-health-cro-assets-to-expand-global-clinical-trial-delivery-across-u-s-and-europe 2026-08-18T23:48:18+00:00 hourly 0.9 https://trial.medpath.com/news/federal-and-industry-sponsors-play-complementary-roles-in-us-cancer-clinical-trials-with-drug-costs-reaching-millions 2026-08-18T22:57:02+00:00 hourly 0.9 https://trial.medpath.com/news/hodgkin-lymphoma-survivors-face-nearly-twice-the-mortality-of-the-general-population 2026-08-18T22:56:48+00:00 hourly 0.9 https://trial.medpath.com/news/kratom-poison-center-reports-climb-from-19-to-1242-in-13-years-as-severe-outcomes-surge 2026-08-18T22:56:36+00:00 hourly 0.9 https://trial.medpath.com/news/celine-dion-details-intensive-rehabilitation-and-immunotherapy-regimen-in-battle-against-stiff-person-syndrome 2026-08-18T22:56:13+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-draft-guidance-clarifying-when-to-submit-an-anda-versus-a-505-b-2-application 2026-08-18T22:56:03+00:00 hourly 0.9 https://trial.medpath.com/news/halozyme-appoints-dannielle-appelhans-to-its-board-of-directors 2026-08-18T22:55:55+00:00 hourly 0.9 https://trial.medpath.com/news/human-hearts-regrow-muscle-after-heart-attack-study-in-circulation-research-finds 2026-08-18T22:54:37+00:00 hourly 0.9 https://trial.medpath.com/news/aqua-medical-advances-pima-procedure-for-type-2-diabetes-with-first-west-coast-patient-and-new-ceo 2026-08-18T22:54:25+00:00 hourly 0.9